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Chapter One 
 
1.1 Introduction 
  
 Immunizations have proven to be one of the most cost-effective and successful public 
health initiatives of the last century, and are credited with being a major contributor to 
our increased life expectancy (MOH, 2005). However, Palestine continues to struggle 
with the problems of under-immunization and periodic resurgences of vaccine-
preventable illnesses (MOH, 2005). Research has shown that under-immunized children 
are likely to be of low SES (MOH, 2004). While attention is often focused on children 
residing in remote villages when efforts are made to increase immunization rates, this 
study focuses on other risk factors and attempts to show that they may be just as, or even 
more influential in affecting immunization rates.  
 
In 2004, the MOH report indicated that less than 80% of 2-year-old children had all of 
the recommended immunizations for their age (MOH, 2004). Children less than 2 years 
of age are the most susceptible to infectious diseases. However, there are no formal 
legislative mandates requiring complete immunizations at this age when children are 
most vulnerable to the devastating consequences of vaccine preventable diseases. With 
the National goal’s being 95% of children having the recommended immunizations by 
age 2 (MOH, 2004), much work remains to be done.   
 
In the last decade, the number of recommended immunizations for 2-year-olds has 
increased from ten to 16 (depending on the brand of vaccine used), and the type of 
vaccine used has also changed. For example, inactivated poliovirus vaccine by injection 
rather than the oral vaccine is now the standard. So, in addition to more vaccines, all of 
them are now administered by injection. There is concern that the increased number of 
injections is a factor in some parents’ reluctance to, and/or procrastination in, having their 
children immunized (Swingle, 2000).   
 
There is also concern that the tremendous success of immunizations in eliminating many 
of the threats of serious infectious diseases in young children may actually decrease 
parents’ understanding of the importance of vaccines. Because many of today’s young 
parents have never had personal experience with vaccine-preventable illnesses, they may 
have more fear of the vaccines than of the illnesses they prevent (Gellin, Maibach, & 
Marcuse, 2000). Childhood immunization is a safe and effective way to prevent many 
infectious diseases and their consequences. Immunizations have important financial 
benefits and improve children’s quality of life. Examples of quality and cost-benefit 
issues include: One in 19 children who get mumps may develop meningitis or 
encephalitis; a child with chicken pox misses 8 or 9 days of school, which results in 
parents missing work; of 100 people infected with diptheria, 5-10 will die; 3 of 10 people 
who get tetanus die; half of the children who get pertussis have to be hospitalized 
(National Committee for Quality Assurance, 2001).   
 
 In considering the many factors that can and do influence immunization rates, careful 
 6 
attention must be focused on the underlying cultural aspects of care-seeking behaviors. It 
may be too easy to attribute the lack of immunization adherence to Israeli occupation 
(MOH, 2005), rather than looking at the myriad of factors that may be involved.  
  
1.2 Problem Statement 
  
The availability of immunizations in Palestine is virtually universal. Cost is no longer a 
major factor since the inception of the EPI Program, which provides free vaccine to 
children whose parents do not have insurance coverage or other means to pay for vaccine. 
Many studies and initiatives have focused on vaccine availability, access, and parental 
compliance, and have resulted in many innovative programs to increase the number of 
children receiving complete and timely vaccinations (MARAM, 2004). Yet, children 
continue to contract vaccine-preventable illnesses because they, and others with whom 
they come in contact, are not fully immunized. In addition, there is a direct correlation 
between childhood immunization rates and the adequacy of pediatric health care in 
general. Under-immunized children typically have fewer preventive health care visits, 
making them less likely to be screened for developmental problems, anemia, sensory 
deficits, and signs of chronic medical conditions and special needs.  
 
The on-going public education campaigns, special clinics and other efforts to increase the 
availability of and access to immunizations have, no doubt, increased the numbers of 
immunized children. However, as reported by MARAM, (2004) children remain 
unprotected and at risk for serious, debilitating, costly and potentially lethal illnesses. 
This is unacceptable.  
 
 
1.3 Problem Significant    
  
Efforts to increase the numbers of immunized children consume a large amount of public 
health resources. Factors influencing immunization programs include cutbacks in 
Ministry of Health budget. Given the National economic climate, if resources allocated 
for public and child health programs decrease, it is increasingly important to concentrate 
efforts on programs and populations that will render the greatest return in increasing the 
rates of childhood immunization and decreasing the incidence of vaccine-preventable 
illnesses. Knowledge of the risk factors for inadequate immunization must be included in 
strategies to increase rates.  
 
 Although health officials in Palestine consider the effects of many cultural influences on 
the immunization status of children (MARAM. 2004), there may be other factors that are 
not considered.  
 
 It is possible that the redirection of some of the efforts to increase immunizations may 
result in significantly greater numbers of protected children. Efforts must not only be 
focused on refugee children, all of whom are now in UNRWA medical care programs 
with excellent access to care. This may well be the cultural group that includes a 
significant number of under-immunized children. If one initiative or cultural 
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consideration that prevents a single death from meningitis, measles or any vaccine-
preventable illness in a child can be identified, the effort is worthwhile.  
    
The role of nurses as leaders in the effort to immunize children is well documented. As 
the level of health care providers with the largest numbers and as the first health care 
provider with whom parents and children come in contact, nurses are vital to the 
immunization effort (American Nurses’ Association, 1994). Nurses must continue their 
leadership roles in the effective and efficient delivery of vaccine to children.  All nurses 
must continue efforts in the education of parents and of other vaccine providers regarding 
the schedule of vaccinations and the necessity for on time, complete immunization of all 
children. And, they must collaborate with public health agencies, schools, social service 
programs, and others in the development of innovative strategies to eliminate barriers and 
to develop policies and programs to assure that all children are immunized.  
   
1.4 Purpose of the Study (Overall objective) 
  
The purpose of this study is to compare the rate of adherence to recommended vaccine 
schedules between refugee and non-refugee 2-year-old children in the West Bank and 
Gaza. Data are needed to show the degree to which non-refugee children contribute to 
immunization non-adherence. The study will also identify cultural influences which may 
affect immunization rates.  
 
 
1.5 Research Questions (specific objectives)  
  
    The following research questions will direct this study:  
1. What are the demographic characteristics of the children from which data will be 
obtained for this study?   
2. Are there differences in immunization adherence for refugee and non-refugee 2-
year-old children in the West bank and Gaza?  
 
 
1.6 Hypothesis  
 
Refugee is not a primary influence of immunization non-adherence for 2-year-olds in the 
West Bank and Gaza. Therefore, strategies to improve immunization adherence in this 
area should be directed to populations other than, or in addition to, the refugee, in order 
to reach the largest number of children in need of immunizations.  
   
1.7 Operational Definitions  
  
Some of the terms utilized in this study have definitions unique to this effort. Those 
definitions are provided in the following section.   
 
Refugee :  For the purpose of this study, children who receive UNRWA medical care  
benefits, as determined by verification of their refugee identification number.  
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Non-refugee:  Children who are not listed in the UNRWA Information System as current 
or previous recipients of Medical benefits.  
 
 Immunization adherence:  Documentation in the child’s medical record that all of the 
vaccines and doses (16 altogether) recommended by the MOH Immunization Practices 
for children who are less than 2 years old, have been received.    
     
Two-year-old:  A child who has reached the second birthday, but has not reached the 
third, as documented by the Birth Certificate or hospital birth record found in the child’s 
medical record.  
     
Demographic characteristics:  For this study, these will include gender, residency, 
service provider, number of siblings and birth order, the mother’s marital status, and 
whether or not she is employed outside the home.  
  
1.8 Conceptual Framework  
  
 Nola Pender’s (1996) Health Promotion Model was used to guide this study. Pender 
identified three areas for consideration: Individual characteristics and experiences, 
including prior related behavior and personal factors such as biological, psychological, 
and socio-cultural issues; behavior-specific cognitions and affect, which include 
perceived benefits, perceived barriers, perceived self-efficacy, activity-related affect, 
interpersonal influences, norms, support and models, and situational influences such as 
options, demand, and aesthetics; and behavioral outcomes including commitment to a 
plan of action and health-promoting behavior (Pender, 1996). 
 
This model is well suited for a study of immunization adherence rates for 2-year-olds and 
cultural influences affecting the rates. Although the model was designed for use with 
adults and this study focuses on children, it is the action of adults, namely the 
parents/care-givers of children that directly affect immunization adherence. Pender 
(1996) advocated nursing intervention to reduce barriers to health care and overcome 
cultural influences that restrict access to care. She encouraged empowerment of 
individuals to value health and the benefits of health-promoting behaviors to such an 
extent that they are willing to overcome barriers to healthy behavior.  
      
The Health Promotion Model should be used as a guide to new directions in health care. 
Dr. Pender pointed out that health care reform is, in actuality, a paradigm shift to health 
promotion and that health promotion and prevention must be central to the development 
of health care for the future (Pender, 1999). Using this model to guide a study of 
immunization adherence is an example of the practical use of a research model in the 
development of strategies to improve health-promoting behaviors. While the study cannot 
incorporate all aspects of the model, interpersonal influences and immediate competing 
demands will be targeted as keys to immunization adherence.  
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1.9 Assumptions  
  
     For the purposes of this study, the following assumptions are presented:  
1. All parents want their children protected from preventable illnesses.  
2. Cost of the vaccine and/or administration of vaccine are not barriers to 
immunization adherence in the West Bank and Gaza.  
3. Health care providers have the ability to help reduce the number of children 
who get ill from vaccine-preventable illnesses with interventions to change the 
behavior of their parents or caregivers.   
  
1.10 Limitations of the study  
  
 This study evaluates the situation at a particular time; it must be recognized that 
services could be influenced by time, circumstances and so on. Field studies also are 
subject to problems of ambiguity and biases, which can positively or negatively 
influence the conclusions drawn from the data. 
 
1.11 Summary  
  
Immunizations are one of the most valuable services available for health promotion and 
illness prevention in young children. Yet, many children remain under-immunized and 
susceptible to serious, potentially lethal illnesses. Children must depend on their 
parents/caregivers to make obtaining immunizations a priority. This study, using Pender’s 
(1996) Health Promotion Model as a guide, seeks to show that non-refugee children, as a 
result of other cultural influences, play a significant role in the problem of immunization 
non-adherence in this area.  
 
Chapter 2 provides a review of literature related to immunization adherence and research 
supportive of the use of Pender’s (1996) Health Promotion Model as a framework for this 
study. It also provides an overview of the diseases for which immunization is required for 
2-year-old children.  
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Chapter Two 
 
Literature Review 
 
This chapter provides a theoretical review of Nola Pender’s (1996) Health Promotion 
Model as it relates to parents’ obtaining immunizations for their children. It also provides 
a review of research studies utilizing theoretical concepts included in, and/or similar to, 
those in Pender’s model.  Additionally, a review of adherence as a concept and the 
variables influencing it, and a discussion of diseases for which immunization has been 
mandated are presented. Studies utilizing other conceptual frameworks, reports of unique 
immunization needs and practices, studies pertaining to adherence to medical regimens, 
and barriers to care are also presented in order to describe fully the body of knowledge 
related to the research questions.  
  
2.1 Theory  
  
Pender’s Models  
 
The Health Promotion Model published by Pender in 1987 and her Revised Health 
Promotion Model published in 1996 (Pender, 1996) help to explain the disease 
prevention and health promotion behaviors of individuals. The Health Promotion Model 
(HPM) provides a framework for personalizing immunization adherence practices. 
Pender’s (1996) behavior-specific cognitions can be identified in studies of immunization 
adherence and reasons for non-adherence. These same behaviors can be applied to 
parents’ behavior in seeking preventive services, including immunizations, for their 
children. The effect of indigence on these behaviors is examined by this study.  
 
The HPM identifies and explains six behavior-specific cognitions and affects in the 
promotion of behavior change:   
1. Perceived benefits of the action result in a mental image of positive 
consequences.   
2. Perceived barriers to actions are real or imagined obstacles that reduce the 
commitment to a plan of action.  
3. Perceived self-efficacy is the process of deciding one’s ability to perform a 
certain task with a certain level of expertise.  
4. Activity related affect is the subjective feeling one gets prior to, during and 
after a behavior.  
5. Interpersonal influences are the effects of the attitudes and beliefs of other 
people.  
6. Situational influences are the effects of considering options available and the 
features of the surroundings that affect a behavior (Neely, 2000).  
 
Identifying the roles these factors play in parents’ decisions regarding obtaining 
immunizations for their children can lend insight into adherence with recommended 
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vaccines and schedules. An example of the perceived benefits of the action resulting in a 
mental image of positive consequences is described by Gellin, Maibach, and Marcuse 
(2000) when respondents to their telephone survey spoke about immunizations keeping 
their healthy children from getting diseases from children who are not immunized.  
  
 Real and imagined obstacles reduce parents’ ability to obtain immunizations for their 
children as described by Evers (2000), Wilson (2000), and Yawn et al., (2000). All 
describe issues such as transportation, competing tasks, past experiences, and the need for 
reminders as such obstacles.  
 
 Perceived self-efficacy in obtaining immunizations was indirectly included in the study 
by Evers (2000) in obtaining respondent’s feelings regarding their responsibility to keep 
their children healthy. Parents who do not obtain needed immunizations were thought by 
other parents to be lazy and irresponsible. The same study described parents feeling 
positive and good about themselves when they did get their children immunized (Evers, 
2000).   
  
Interpersonal influences that affect immunization adherence include religious beliefs, 
negative past experiences, and inaccurate information. An example of such 
misinformation is parents thinking that if the child has any illness, immunization should 
be withheld until the child is completely well (Wilson, 2000).   
 
 Situational influences, including the barriers described previously, can be overcome by 
developing optional methods of service delivery. These may include instituting recall and 
reminder programs, providing incentives and rewards, and creating other means of 
changing negative influences into positive outcomes (Hillman et al., 1999; Houseman et 
al., 1997; Yawn et al., 2000).  
  
 
2.2 UNRWA as a Key Service Provider 
 
The United Nations Relief and Works Agency (UNRWA) was established on December 
8th, 1949 as a result of the first Arab-Israeli conflict.  The Agency, headquartered in 
Beirut at the time, became operational in May 1950 and began responding to the 
immediate humanitarian needs of about 880,000 Palestinian refugees. Since then the 
Agency has grown into the largest United Nations organization in the region, employing 
more than 22,000 staff members including teachers, health workers, social workers and 
other service providers to cover its missions in the fields of health, education, 
employment and social relief. The majority of the employees are Palestinian refugees. 
The agency operates about 900 facilities providing education, health, relief and social 
services for the growing population of refugee who are now more than 4 million in 
number.(Switzerland, Office of United Nations High Commissioner for Refugee, 1999). 
 
Currently UNRWA operations are handled by 5 separate field offices located in Jordan, 
Syria, Lebanon, Gaza, and the West Bank. The agency headquarters are located in Gaza 
and Amman, having been relocated from Vienna. UNRWA is a subsidiary organization 
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of the United Nations (UN). (UNRWA, 2003). 
2.3 Health Department 
 
The mission of the UNRWA health program is to protect and promote the health status of 
Palestinian refugees and to meet their basic health needs. The agency’s strategic approach 
is to provide quality primary health care and essential health services by using 
appropriate technology in order to reduce recurrent staff costs, enhancing the process of 
institutional capacity building in order to improve staff performance and to make optimal 
use of the limited financial and human resources available to the department. (United 
Nations Relief and Works Agency, 2003). 
 
Since 1950 the WHO Eastern Mediterranean Regional Office (EMRO) and staff have 
been providing technical supervision to UNRWA’s health care programme; WHO 
policies and technical advice from the WHO Director of Health are disseminated through 
the EMRO Commissioner General Director to the UNRWA clinics in the region, 
influencing their technical activities and overall health program.(Switzerland, WHO, 
1987). 
 
UNRWA provides Primary Health Care to registered refugees through 122 outpatient 
facilities offering outpatient medical care, disease prevention and control, mother and 
child health, family planning, and health education and promotion.  The Agency’s 34 
primary health care facilities in the West Bank and Gaza have developed an effective 
programme of disease prevention and control, including vaccine-preventable diseases.  
Immunization services are an integral part of the comprehensive maternal and child 
health care program and all health center points follow the open door policy with respect 
to immunization so that essential vaccines are given or confirmed as having been 
received at every contact. (UNRWA,2001). 
 
2.4 UNRWA Immunization Program 
 
2.4.1: UNRWA Immunization Program West Bank: 
 
 UNRWA adapted the WHO program on immunization in its five fields of operation in 
the region in close coordination with the host countries. In the West Bank the UNRWA 
immunization program for children 0-24 months of age follows the immunization 
schedule shown below: 
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Table 2.1 Total Doses Required Per Antigen for Children 0-24 Months of Age 
 
 
Antigen 
Total # of Doses in the First 
Two Years of Life 
BCG 1 
Hepatitis B 3 
IVP 2 
DPT 4 
OPV 4 
Measles 1 
MMR 1 
 
 
 
The schedule shown in Tables 2.1 and 2.2 is the same vaccination schedule used by the 
host country (the Palestinian Authority) Ministry of Health.  
UNRWA have a different immunization schedule in her five fields of operation, this is 
coordinated with the host country and UNICEF, in according to needs and budget. 
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Table 2.3 Immunization Schedule for Children below 2 Years in Jordan. 
 
 
 
2.4.2: UNRWA Immunizations in Jordan: 
 
In Jordan The EPI program in Jordan reached routine immunization coverage of more 
than 95% in 1996. Mainly due to an adverse event that occurred during a school 
vaccination campaign with Td, immunization coverage figures decreased and remained 
less than 90% up to 1999. In 2000, Jordan reported coverage of 91% with DPT3, 94% 
with OPV3, 92% with measles and 93% with HBV3. The EPI program made a lot of 
achievements especially in measles and neonatal tetanus elimination and in new vaccines 
introduction. 
 
A nationwide measles catch-up campaign was successfully conducted in two rounds 
(1997-99). This has resulted in an important decrease in measles confirmed cases from 
around 400 cases reported annually since 1994 (except the outbreak registered in 1997 
with 7026 cases) to only 115 cases in 1999 and 32 cases in 2000.Hib vaccine was 
recently introduced in the routine EPI,this is why this vaccine is in UNRWA schedule 
too.(VPDs,2004). 
 
As we notice the UNRWA immunization schedule in Jordan differ from that of the west 
bank by the antigen given which are 18 antigen while in the west bank field they are only 
16. In Jordan Hib antigen is included and is given twice in the third and fourth month of 
age. OPV which is given in the west bank at 2 months is given in Jordan at Birth or at 
first registration. 
Age\Category Vaccine 
At Birth\first registration BCG 
OPV 
2 Months Hepatitis B+DPT 
OPV 
Hib 
3 Months Hepatitis B + DPT 
OPV 
Hib 
4 Months Hepatitis B+ DPT 
OPV 
Hib 
9 Months Measles 
15 Months DPT 
OPV 
MMR 
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2.4.3: Immunization program in Israel. 
 
In Israel a state with large resources, and enough funding to the health system, better 
program exist, with more antigens, and modifications up-to-date. 
Israel used to coordinate specially the immunization program with the Palestinian 
authority; steps are chronolized in cases of outbreaks. 
 
 
Table 2.4 Immunization Schedule for Children below 2 Years in Israel 
 
Age HBV DTaP 
IPV+Hib 
DTaP 
Hib 
Polio 
Sabin 
MMR HAV VARILIRIX 
At Birth    *       
1 Month    *       
2 Months           *      
4 Months        *      *    
6 Months     *      *     *    
1 Year        *      *     *   
18 Months                   * 
24 Months                   * 
 
In Israel only 13 antigens are included in immunization of children till 2 years of age but 
it differs from those given in UNRWA clinics whether in the west bank or Jordan field by 
that it includes: 
1) Immunization against Hepatitis A given in two doses at 18 and 24 months of age. 
2) Immunization against Varecilla given at 12 months of age 
3) The immunization schedule includes vaccinations with 5 antigens together at 2,4 
and 1 year and immunization with 4 antigens at six months of age 
 
Countries of the eastern Mediterranean region and UNRWA are committed to achieving 
the goal of measles elimination by the year 2010. Major steps towards achievement of 
this target include conducting catch up measles immunization campaigns, and achieving 
improvements in routine measles and rubella immunization and in laboratory-confirmed 
surveillance programs for every case of ―rash and fever‖ (suspected measles/rubella). 
(UNRWA, Child Rights, 2005). 
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Table 2.5 Coverage rate for Mediterranean region 2004 (EMRO report 2004). 
  
Category                                                 % Year 
Infants attended by trained personnel (%) 99 1998 
Infants fully immunized with BCG (%) 58 2004 
Infants fully immunized with DPT (%) 95 2004 
Infants fully immunized with OPV (%) 95 2004 
Infants fully immunized with measles 
vaccine (%) 
21 2004 
Infants fully immunized with Hepatitis B 
vaccine (%) 
95 2004 
 
Numbers shown in the table up for the Mediterranean region show low coverage for 
measles, which is for concern, while it is better in the West bank and Gaza according to 
the EMRO report for the year 2004. 
 
Table 2.6 Immunization coverage in West Bank and Gaza (EMRO Report 2003). 
 
 
Again the worst immunization coverage is noticed for the measles with only 36%, and 
only BCG have 100% coverage because it is given at birth. 
 
 Category                                                                 % Year 
Infants attended by trained personnel (%) 95 2003 
Infants fully immunized with BCG (%) 100 2003 
Infants fully immunized with DPT (%) 98 2003 
Infants fully immunized with OPV (%) 98 2003 
Infants fully immunized with measles vaccine 
(%) 
36 2003 
Infants fully immunized with Hepatitis B 
vaccine (%) 
98 2003 
 18 
According to CDC data for 2002,the percentage of deaths from vaccine preventable 
disease is still very high, especially from Pneumococcal and Measles and represent about 
50% of VPDs. 
 Immunization is among the most successful and cost-effective public health 
interventions Immunization programs have led to eradication of smallpox, elimination of 
measles and poliomyelitis in regions of the world, and substantial reductions in the 
morbidity and mortality attributed to diphtheria, tetanus, and pertussis. The World Health 
Organization (WHO) estimates that 2 million child deaths were prevented by 
vaccinations in 2003. Nonetheless, more deaths can be prevented through optimal use of 
currently existing vaccines.(Vaccine preventable Deaths and the global immunization 
Vision and strategy 2006).   
 
 
 
 
  
 
Figure 2.1 Percentage of deaths from vaccine-preventable diseases (Pfeifer M.2003) 
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UNRWA is still the second most frequently accessed health provider in the West Bank 
and the first for the Palestinian refugee population, resulting in an increasing demand on 
services, and a high average workload of around 100 medical consultations per physician 
per day. UNRWA provides assistance to Palestinian registered refugees by reimbursing 
the costs of their referral care at the contracted hospital in each of its 3 areas of operation 
-- the south (Hebron), north (Nablus) and middle (Jerusalem and Jericho).   
 
 
Immunization is a process used to initiate or augment resistance to infectious diseases. 
The ultimate goal is to prevent, and in some cases eradicate, potentially serious, life-
threatening diseases.  Immunity against a variety of bacterial and viral agents can be 
induced either actively or passively. 
 
2.5 Immunity 
 
Active immunity is induced by using inactive or attenuated live organisms or   their 
products. Live attenuated vaccines include those for poliomyelitis (OPV), measles, 
mumps and rubella, and BCG vaccine.  (Eddelston and Pierni, 1999).  
 
Bacterial and viral vaccines such as whooping cough, typhoid and inactivated 
poliomyelitis (IPV) vaccines contain inactivated organisms. Others such as influenza and 
pneumoccoal vaccine contain immunizing components of the organisms; tetanus and 
diphtheria vaccines contain toxoid that is, toxins inactivated by treatment with 
formaldehyde. (Hay and Hayward, 2001). 
 
Most vaccines produce their protective effect by stimulating the production of antibodies 
which are detectable in the serum by laboratory tests. BCG vaccine promotes cell-
mediated immunity which is demonstrated by a positive tuberculin skin test. A first 
injection of inactivated vaccine or toxoid in a subject who has not had prior exposure to 
the antigen produces a slow antibody or antitoxin response of predominantly IgM 
antibody- primary response. Two injections may be needed to produce such a response. 
Depending on the potency of the product and time interval, a further injection will lead to 
an accelerated response in which the antibody or antitoxin titer (IgG) rises to a higher 
level, known as the secondary response. Following a full course, the antibody or antitoxin 
levels will remain high for months or years. But even if the level of detectable antibody 
falls, the immune mechanism has been sensitized and a further dose of vaccine reinforces 
immunity. (Beniton, 1979). 
 
Some inactivated vaccines contain adjuvant, substances which enhance the antibody 
response. Examples are aluminum phosphate and aluminum hydroxide, which are 
contained in adsorbed diphtheria/tetanus/pertussis vaccine, and adsorbed 
diphtheria/tetanus vaccine.  
 
Live attenuated virus vaccines such as measles, rubella and mumps promote a full, long-
lasting antibody response after one dose. Live poliomyelitis vaccine (OPV) requires three 
doses. An important additional effect of poliomyelitis vaccine is the establishment of 
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local immunity in the intestine.(National committee for Quality Assurance,1993). 
 
Passive immunity: results from the injection of human immunoglobulin; the protection 
afforded is immediate but lasts only for a few weeks. There are 2 types: 
 
 Human normal immunoglobulin (HNIG): derived from the pooled plasma 
of donors and containing antibody to viruses which are currently prevalent 
in the general population  
 
 Specific immunoglobulin for tetanus, hepatitis B, rabies, and 
varicella/zoster: obtained from the pooled blood of convalescent patients 
and donors recently immunized with the relevant vaccine. Each such 
immunoglobulin therefore contains antibody at a higher titer than that 
present in normal immunoglobulin. (Ghaffar, 2003). 
 
Immunization (vaccination): Vaccines are harmless agents that the body perceives as 
enemies. They are molecules, usually but not necessarily proteins, that elicit an immune 
response and provide protective immunity against a potential pathogen. Immunity to a 
virus normally depends on the development of an immune response to antigens on the 
surface of a virally infected cell or on the surface of the virus particle itself. There may be 
more than one surface glycoprotein on a virus and one of these may be more important in 
the protective immune response than the others; this antigen must be identified for a 
logical vaccine that blocks infectivity. 
 
In order to develop a successful vaccine, certain characteristics of the viral infection must 
be known. One of these is the site at which the virus enters the body. (Immunization 
Against Infectious Diseases, 1992). 
 
1) Infection via mucosal surfaces of the respiratory tract and gastro-intestinal tract. 
2) Infection via mucosal surfaces followed by systemic spread via the blood and/or 
neurons to target organs. Virus families in this group are: measles virus; mumps virus; 
herpes simplex virus; varicella virus; and hepatitis A and B viruses. 
3) Infection via needles or insect bites, followed by spread to target organs, like hepatitis 
B virus. 
 
Four different types of vaccines are currently available: 
 Attenuated (weakened) vaccines contain live virus; examples include the measles, 
mumps, and rubella (MMR) vaccine and varicella (chicken pox) vaccine. These vaccines 
last longer than other vaccines, but many cause serious infections in people with 
compromised immune systems. 
 Killed (inactivated) vaccines involve killed (inactivated) viruses or bacteria; for 
example, the influenza vaccine uses killed virus. These vaccines are safe, even in people 
with compromised immune systems. 
 Toxoid vaccines contain a toxin produced by the bacterium or virus. For example, 
the diphtheria and tetanus vaccines are actually toxoids 
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 Biosynthetic vaccines contain synthetic (man-made) substances which appear to 
be antigens to the immune system. For example, the Hib (Haemophilus influenza type B) 
conjugate vaccine is a biosynthetic vaccine. (Polnay and Hull, 1985). 
 
There are many problems inherent in developing a good protective anti-viral vaccine. 
Among these are: 
 Different types of virus may cause similar diseases--e.g. common cold 
 Antigenic drift and shift -- This is especially true of RNA viruses  
 Large animal reservoirs. If these occur, reinfection after elimination from 
the human population may occur. 
 Recombination and mutation of the vaccine virus in an attenuated vaccine. 
Despite these problems, anti-viral vaccines have, in some cases, been spectacularly 
successful, even in some cases leading to the elimination of the disease from the human 
population. (Ghaffar,2003).  
 
Attenuated vaccines have many advantages and disadvantages.  
 
Advantages 
 
 They activate all phases of the immune system and they elicit humoral IgG 
and local IgA  
 They raise an immune response to all protective antigens. Inactivation, 
such as by formaldehyde in the case of the Salk vaccine, may alter 
antigenicity 
 They offer more durable immunity and are more cross-reactive.  
 They cost less to produce 
 They give quick immunity in the majority of vaccines 
 In the cases of polio and adenovirus vaccines, administration is easy  
 They are easy to transport  
 They can lead to elimination of wild type virus from the community 
 
Disadvantages 
 
 Mutation of the virus; this may lead to reversion to virulence (this is a 
major disadvantage) 
 Spread to contacts of vaccine that have not consented to be vaccinated 
Virus from the attenuated vaccine itself can be spread to un-immunized 
children who come in contact with recently immunized children. Although 
this can result in more cases of disease, since the vaccine virus is usually 
less serious than the wild virus, the natural immunities that develop in 
those who contract the virus from the vaccine can be an advantage in 
communities where immunization coverage is not 100 %.) 
 Vaccine virus can mutate and spread, resulting in circulation of virus that 
is less susceptible to vaccine.   
 Live viruses are a problem in patients with immunodeficiency disease 
(Orenstein, 2000). 
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Inactivated vaccines also have many advantages and disadvantages. 
 
Advantages 
 
 They give sufficient humoral immunity if boosters are given 
 There is no mutation or reversion (This is a big advantage) 
 They can be used with immuno-compromised patients 
 Sometimes they perform better in tropical areas 
 
Disadvantages 
 
 Some vaccines do not raise immunity 
 Boosters tend to be needed 
 There is little mucosal / local immunity (IgA) 
 They are more expensive (Polnay and Hull, 1985). 
 
2.6 Vaccine-preventable Diseases 
 
2.6.1: Tuberculosis (BCG) 
 
Human tuberculosis is caused by infection with mycobacterium tuberculosis or 
mycobacterium bovis and may affect any part of the body, including the brain, the 
kidneys and the bones; but most commonly it affects the lungs (Pulmonary 
Tuberculosis).  The infection is typically acquired through aerosol spread by coughing or 
sneezing; such transmission is only likely when the index case is sputum smear-positive 
for the bacillus. The primary stage of the disease may be symptom-free, or the individual 
may experience a flu-like illness.  In the secondary stage, called active disease, there 
might be a slight fever, night sweats, weight loss, fatigue and various other symptoms, 
depending on the part of the body affected.  Tuberculosis of the lung is usually associated 
with a dry cough that eventually leads to a productive cough with blood-stained sputum.  
There might also be chest pain and shortness of breath.  This secondary stage, if affecting 
the lungs, is the contagious stage when the bacteria can be spread to others.(Core 
curriculum, 1994). 
 
Tuberculosis is on the rise and is revisiting both the developed and developing world.  
Globally, it is the leading cause of deaths resulting from a single infectious disease.  
Currently, it kills three million people a year and, if the present trend continues, it is 
likely to claim more than 30 million lives within the next decade.  Recent increases in 
migration have rapidly mixed infected with uninfected communities and contributed to 
the spread of the disease. (Chaisson and Slutkin, 1989). 
 
BCG vaccine 
 
 It is freeze-dried live attenuated Mycobacterium bovis. 
 It confers good immunity in children against the more severe forms of TB 
such as meningitis and military TB. 
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 The diluents and the vaccine must be stored cold in the main compartment of 
the refrigerator. 
 After reconstitution, the vaccine is easily damaged by sunlight or heat. 
 It should not be shaken after reconstitution, as shaking damages the vaccine 
 Proper mixing of BCG vaccine should be done whenever a dose is drawn in 
order to ensure proper dosing of vaccine and avoid side effects:  draw the 
reconstituted vaccine slowly into the syringe and inject it slowly back into the 
ampoule or vial. Then inject it to the upper part of the left arm. 
 The vial of reconstituted vaccine should be discarded at the end of the 
immunization session 
 There is no need to repeat BCG vaccination if no scar develops 
 There is no need for tuberculin testing before giving BCG. 
 
BCG vaccine should not be given to subjects who are: 
 
 Receiving corticosteroid or other immunosuppressive treatment. 
 Suffering from a malignant condition such as lymphoma, leukemia, or other 
tumor of the reticuloenothelial system 
 Who are HIV positive  
 With pyrexia.(United States, CDC, Core Curriculum, 2001). 
 
False contraindications for immunization may include allergy, asthma, and hay fever. 
Prematurity or small-size-for-gestational-age, malnutrition, a history of jaundice after 
birth, or a family history of convulsions.  
 
About 2 weeks after immunization a small tender red swelling appears at the vaccination 
site which may ulcerate and become a scar. Keloid formation at the injection site is a not 
uncommon, but largely avoidable complication of BCG immunization, injection of the 
vaccine in the deltoid muscle near the middle of the upper arm may have lower risk of 
keloid formation. 
 
BCG immunizations are to be given at birth or at first registration as a single dose of 0.05 
intradermal.(United Nations Relief and Works Agency, Technical Instruction,2001). 
 
2.6.2: Poliomyelitis: OPV, IPV 
  
Poliomyelitis is an acute illness following invasion of the gastro-intestinal tract by one of 
the three types of polio virus (1, 2 and 3). The virus has a high affinity for nervous tissue 
and the primary changes occur in neurons. The infection may be clinically unapparent, or 
range in severity from a non-paralytic fever to aseptic meningitis or paralysis. Symptoms 
include headache, gastro-intestinal disturbance, malaise and stiffness of the neck and 
back, with or without paralysis. The incubation period ranges from three to 21 days, and 
cases are most infectious from seven to ten days before and after the onset of symptoms; 
virus may be shed in the faeces for up to six weeks or longer. (Ghaffar, 2003). 
 
There are two types of polio vaccine, both of which were developed in the 1950s. The 
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first, developed by Jonas Salk, is a formalin-killed preparation of normal wild type polio 
virus. This is grown in monkey kidney cells and the vaccine is given by injection. It 
elicits good humoral (IgG) immunity and prevents transport of the virus to the neurons 
where it would otherwise cause paralytic polio. A second vaccine developed by Albert 
Sabin is a live viral vaccine that was produced empirically by serial passage of the virus 
in cell culture. It replicates a normal infection since the virus actually grows in the 
vaccine and it elicits both humoral and cell-mediated immunity. It is given orally, a route 
that is taken by the virus in a normal infection since the virus is passed from human to 
human by the oral-fecal route. The immunity that results from the Sabin vaccine lasts 
much longer that that of the Salk vaccine, making fewer boosters necessary. The Sabin 
vaccine has the potential to wipe out wild type virus whereas the Salk vaccine only stops 
the wild type virus getting to the neurons -- it is still replicated in the human gut.( Beniton 
,1979 ).  
 
OPV is composed of the three types of live/attenuated poliomyelitis virus. It is damaged 
very easily by heat and light and it confers both intestinal and systemic immunity. The 
neonatal OPV dose is given during the first month after birth. The interval between this 
dose and the next OPV is at least three weeks, with two drops of OPV given orally at two 
months, four months six months and twelve months. 
 
IPV, a trivalent killed poliomyelitis virus vaccine that confers systemic immunity, is 
given subcutaneously in the left upper arm in two 0.5 ml doses at first registration (at one 
month) and one month after that. It is used in combination with OPV to reduce the risk of 
vaccine-related paralysis. IPV is less sensitive to heat and light than OPV. Moderate 
fever and mild erythematous reaction at the site of injection maybe observed. (Medecies 
Sans Frontiers, 1997). 
 
Contraindications include acute or febrile illness, vomiting or diarrhea, which should 
prompt a postponement of immunization, malignant conditions, treatment with 
corticosteroids and radiation therapy.(Beniton ,1979).  
  
2.6.3: Hepatitis B (HBV) 
 
Hepatitis B is transmitted parenterally. Transmission most commonly occurs as a result 
of blood to blood contact, including injury with contaminated sharp instruments and 
sharing of needles by intravenous drug abusers, following vaginal or anal intercourse or 
by prenatal transmission from mother to child. Transmission has also rarely followed 
bites from infected persons. Transfusion-associated infection is now rare as treatment of 
blood products has eliminated these as a source of infection.(Ghaffar,2003). 
 
The illness usually has an insidious onset with anorexia, vague abdominal discomfort, 
nausea and vomiting, sometimes arthralgia and rash which often progresses to jaundice. 
Fever may be absent or mild. The severity of the disease ranges from apparent infections, 
which can only be detected by liver function tests and or the presence of serological 
markers of acute HBV infection (e.g. HBsAg, anti HBc IgM), to fulminating fatal cases 
of acute hepatic necrosis. Among cases admitted to hospital the fatality rate is about 1%. 
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The average incubation period is 40-160 days but occasionally can be as long as nine 
months.(The Blue Book,2005). 
 
About 2-10 of those infected as adults become chronic carriers of the hepatitis B virus 
with hepatitis B surface antigen (HBsAg) persisting for longer than 6 months. Those 
infected as children more frequently become chronic carriers than those infected as 
adults, and 90% of those infected parenterally become chronic carriers.  
 
A proportion of antigen carriers develop chronic hepatitis. Sometimes there is impairment 
of liver function tests; biopsy findings range from normal to active hepatitis with or 
without cirrhosis. The prognosis of the liver disease in such individuals is at present 
uncertain, but it is known that some will develop hepatocellular carcinoma. (Berham and 
Vanghan, 1987). 
 
Hepatitis B vaccine contains hepatitis B surface antigen (HBsAg) adsorbed on aluminum 
hydroxide adjuvant. An antibody level of 100 miu/ml is generally considered to be 
protective. Antibody titers should be checked two to four months after completion of a 
full course (3 doses) of HBV. Poor responders (anti-HBs 10-100) and non responders 
(less than 10) should be considered for a booster dose or, possibly for a repeat course of 
vaccine. The duration of antibody persistence is not known precisely. At present it is felt 
that individuals who continue to be at risk of infection should receive a booster dose three 
to five years after the primary course, and it is important to recognize that immunization 
against hepatitis B must not encourage relaxation of good infection control procedures. 
Babies born to mothers who are HBeAg positive, who are HBsAg positive without 
markers, or who have had acute hepatitis B during pregnancy should receive HBIG as 
well as active immunization. Health care personnel who have direct contact with blood or 
blood-stained body fluids such as doctors, surgeons, dentists, nurses, midwives and dayas 
should receive the vaccine. Contraindications include febrile infections and pregnancy, 
which can result in severe disease for the mother and chronic infection in the newborn. 
Soreness and redness to local pigmentation changes may occur after injection, and in 
some cases influenza-like syndromes, arthritis, arthralgia, and abnormal liver function 
tests.(Immunization Against Infectious Diseases, 1992). 
 
HBV efficacy is high if the first dose is given to an infant as soon after delivery as 
possible; the second and third doses are given at one month and six months of age. Each 
dose is a 0.5ml injection given intramuscularly at the lateral aspect of thigh. (United 
Nations Relief and Works Agency, 2001). 
 
2.6.4: Diphtheria/Pertussis/Tetanus (DPT) 
 
 Diphtheria is an acute infectious disease affecting the upper respiratory tract and 
occasionally the skin. It is characterized by inflammatory exudates that form a grayish 
membrane in the respiratory tract which may cause obstruction. The incubation period is 
from two to five days. The disease is communicable for up to four weeks, but carriers 
may shed organisms for longer. A toxin is produced with diphtheria bacilli which affect 
in particular the myocardium, nervous and adrenal tissues. The disease is spread through 
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contact with droplets and/or with articles soiled by infected persons (fomites). (Hay and 
Hayward, 2001). 
 
 Pertussis is a highly infectious bacterial disease caused by bordetella pertussis and 
spread by droplet infection, with an incubation period of seven to ten days. A case is 
infectious from seven days after exposure to three weeks after the onset of typical 
paroxysms. The initial catarrhal stage has an insidious onset and is the most infectious 
period. An irritating cough gradually becomes paroxysmal, usually within one to two 
weeks, and often lasts for two to three months. In young infants the typical ―whoop‖ may 
never develop and coughing spasms may be followed by periods of apnea. Pertussis may 
be complicated by bronchopneumonia, repeated post-tussive vomiting leading to weight 
loss, and by cerebral hypoxia with a resulting risk of brain damage. Severe complications 
and deaths occur most commonly in infants under six months of 
age.(Switzerland,WHO,1986). 
  
 Tetanus is an acute disease characterized by muscular rigidity with superimposed 
agonizing contractions. It is induced by the toxin of anaerobic tetanus bacilli which grow 
at the site of an injury. The incubation period, typically ten days in duration, can last from 
four to 21 days. Tetanus spores are present in soil and may be introduced into the body 
during injury, often through a puncture wound, or through burns or trivial, unnoticed 
wounds. Neonatal tetanus due to infection of the baby’s umbilical stump is a significant 
cause of death in many countries of the third world. Tetanus is not spread from person to 
person. The elderly are at highest risk, with women being at greater risk than 
men.(Beniton, 1979).  
 
 DPT vaccine: the diphtheria component is a toxoid which is highly stable in high 
temperatures but is easily damaged by freezing. The potency of the bacteria component in 
Td vaccine (a vaccine for adults that combines tetanus toxoid and a lower dose of 
diphtheria vaccine than is found in the DT vaccine for children) is around one-fifth of the 
potency of the diphtheria component in DPT or DT. The tetanus component is a toxoid 
which is easily damaged by freezing.( Berham and Vanghan,1987). 
 
The pertussis component is killed whole cell pertussis bacteria. It is the most easily 
damaged part of DPT, and is susceptible to heat. It is effective in preventing serious 
illness but does not protect completely against infections with the organism. Pertussis 
vaccine should not be given to children with a history of convulsions. (National Vaccine 
Advisory Committee. 1999) Four 0.5 ml. doses of DPT are given intramuscularly at the 
lateral aspect of the thigh at ages two months, four months, six months, and twelve 
months. (Wiliams and Dajda, 1980). 
 
Adverse reactions include swelling and redness at the injection site, crying, screaming 
and fever may occur. More severe neurological conditions including encephalopathy and 
prolonged convulsions resulting in permanent brain damage or death have been 
reported.(Christopher and Cynthia, 1991). 
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2.6.5: Measles, Mumps, Rubella (MMR) 
 
Measles, mumps and rubella are all spread primarily via the aerosol route. Measles and 
mumps viruses belong to the Paramyxovirus family and are enveloped, non-segmented, 
negative-sense RNA viruses with helical symmetry.(Philip, 2003). 
 
 Measles (Rubeola): The word measles is derived from the German word for blister. 
Infection occurs via an aerosol route and the virus is very contagious. It replicates 
initially in the upper and lower respiratory tract, followed by replication in lymphoid 
tissues leading to viremia and growth in a variety of epithelial sites. The disease develops 
one to two weeks after infection. Uncomplicated disease is characterized by: Fever (38 C 
or above); respiratory tract symptoms such as a running nose (coryza) and cough; 
conjunctivitis; and/or Koplik's spots on the mucosal membranes small (1 to 3mm), 
irregular, bright red spots, with bluish-white specks at the centers. The patient may get an 
enormous number of blisters and red areas may develop into a confluent Maculopapular 
rash which extends from the face to the extremities. This seems to be associated with T-
cells targeting infected endothelial cells in small blood vessels (Switzerland, WHO, 
1986). 
 
The infection is prostrating but recovery is usually rapid. The peak of infectiousness 
occurs before the onset of obvious symptoms (e.g. Koplik’s spots, rash). Measles tends to 
be more severe in adults and the very young (under 5 years of age) and less severe in 
older children and teenagers.  
If a patient has an impaired cell-mediated immune response, there is continued growth of 
the virus in the lungs leading to giant cell pneumonia (such patients may not have a rash). 
This is rare, but often fatal. The reason for the giant cells is that since F protein can 
function at physiological pH, it can facilitate cell-cell fusion. Since the virus grows in the 
epithelia of the nasopharynx, middle ear and lung, all of these sites may then be 
susceptible to secondary bacterial infection. Otitis media and bacterial pneumonia are 
quite common. The outcome of the disease is affected by the patient’s nutritional status 
and access to medical care. Measles is still a major killer in underdeveloped countries, 
especially in areas with severe vitamin A deficiency. Treating sick children with Vitamin 
A has resulted in some reduction in morbidity and mortality. Pneumonia accounts for 
60% of deaths from measles. Clinical aspects of measles include pneumonia (life 
threatening), otitis media, oral mucosa spots (kopliks) potentially progressing to severe 
ulcerating lesions, conjunctivitis, and maculopapular rash to hemorrhage (black 
measles).(United States,CDC,Epidemiology,2001).  
Measles illness during pregnancy leads to increased rates of premature labor, spontaneous 
abortion, and low birth weight among affected infants (2-5). Birth defects, with no 
definable pattern of malformation, have been reported among infants born to women 
infected with measles during pregnancy, but measles infection has not been confirmed as 
the cause of the malformations 
  
Mumps:  The name comes from the British word "to mump," that is to grimace or grin – 
the appearance of grimacing or grinning in mumps patients results from parotid gland 
swelling although other agents can also cause parotitis. Clinically, mumps is usually 
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defined as acute unilateral or bilateral parotid gland swelling that lasts for more than two 
days with no other apparent cause.(Lewkowicz,1989). 
 
 Mumps is caused by a Paramyxovirus. There is one serotype of the virus and in an 
affected patient it can be found in most body fluids including cerebro-spinal fluid, saliva, 
urine and blood. Mumps is very contagious and is usually acquired from respiratory 
secretions and saliva via aerosols or formites. The virus is secreted in urine and so urine 
is a possible source of infection. It is found equally in males and females.  The virus 
infects the upper and lower respiratory tract leading to local replication. The virus spreads 
to lymphoid tissue which, in turn, leads to viremia. The virus thus spreads to a variety of 
sites including the salivary and other glands and other body sites (including the 
meninges). The average time to full manifestation of disease is 2 - 3 weeks but fever, 
anorexia, malaise, and/or myalgia may occur during the prodromal phase.(Walters and 
Richard,2000). 
 
The symptoms of mumps include:  
Fever, parotitis:  Pain from parotitis swelling persists for 7 - 10 days. This is the most 
common feature of mumps and is seen in about 40 of patients. It may be unilateral or 
bilateral depending on which salivary glands are infected by the virus.  
Meningitis:  Aseptic meningitis is usually mild, and affects about three times more males 
than females. In symptomatic meningitis the patient experiences stiffness of the neck and 
a headache which usually resolves in up to 10 days with no further problems. Mumps-
related meningitis is more severe in adults. In very rare cases mumps can result in 
encephalitis.  
Deafness:  Mumps was a leading cause of acquired deafness before the advent of mumps 
vaccine. It is usually unilateral. Deafness may improve with time but is usually 
permanent. 
Orchitis (testicular inflammation): This is especially severe in adolescent and adult males 
and occurs in about 50% of cases, sometimes occurring along with parotitis. The painful 
swelling diminishes after about seven days but tenderness can last for weeks. In 70% of 
cases, orchitis is unilateral and results in some degree of testicular atrophy. Damage tends 
to be patchy and rarely causes infertility.  
Pancreatitis: Pancreatitis with transient hyperglycemia that resolves is an infrequent side 
effect of mumps.  
Myocarditis:   Myocarditis is observed from electrocardiograms in a minority of patients 
but is usually otherwise asymptomatic.  
Rare complications: These include nephritis, arthralgia (joint pain) and arthritis (joint 
inflammation).(Hay and Hayward,2001). 
 
 Rubella:  Rubella is a mild infectious disease, most common among children four to 
nine years of age. It causes a transient erythematous rash; lymphadenopathy involving the 
post-auricular and sub-occipital glands; and occasionally in adults, arthritis and arthragia. 
Clinical diagnosis is unreliable since the symptoms are often fleeting and can be caused 
by other viruses; in particular the rash is not a diagnostic sign of rubella. A history of 
rubella should therefore not be accepted without serological evidence of previous 
infection. The incubation period is 14-21 days and the period of infectivity is from 1 
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week before until four days after the onset of a rash. Maternal rubella infection in the first 
eight to ten weeks of pregnancy results in fetal damage in up 90% of infants and multiple 
defects are common in the Congenital Rubella Syndrome (CRS). The risk of damage 
declines to about 10-20% by 16 weeks gestation; after this stage of pregnancy fetal 
damage is rare. Fetal defects include mental handicap, cataract, deafness, cardiac 
abnormalities, intrauterine growth retardation, and inflammatory lesions of the brain, 
liver, lungs, and bone marrow. The only defects which commonly occur alone are 
perceptive deafness and pigmentary retinopathy following infection after the birth but 
perceptive deafness may be detected later.(Rubella: A medical Dictionary,2004). 
The measles, mumps and rubella (MMR) vaccine has been around for nearly 30 years, 
and is now used in over 90 countries to control major childhood diseases.  Measles is 
responsible for approximately one-third of the estimated 1.4 million deaths every year 
due to vaccine-preventable childhood diseases.   
An immunization campaign against measles, mumps and rubella was launched on 5 
May for 1.2 million children and young people in the West Bank and Gaza strip.   
 
 
 MMR vaccine: The vaccine is made from a combination of live attenuated 
measles, mumps and rubella viruses, it was introduced in 1993 , this vaccine must 
be reconstituted with the appropriate diluent’s; once reconstituted the vaccine 
loses its potency very quickly and must be used in the same immunization 
session. The vaccine must be protected from the light at all times even after being 
reconstituted.(Berham and Vanghan,1987). 
 
 The MMR vaccine is given as a single 0.5 ml. dose injected subcutaneously in the 
upper left arm at 15 months of age, while the measles vaccine is given at 9 
months of age. Mild fever, running nose, and mild skin rash may occur after 
immunization. (Stratton ,Gable and Shetty,2001). 
 
 Two doses of MMR vaccine separated by at least 1 month (i.e., a minimum of 28 
days) and administered on or after the first birthday are recommended for all 
children and for certain high-risk groups of adolescents and adults. The 
recommended 1-month interval between successive doses of MMR or other 
measles-containing vaccine is based on the principle that live virus vaccines not 
administered at the same time should be separated by at least 1 month. 
 MMR is the vaccine of choice when protection against any of these three diseases 
is required on or after the first birthday, unless any of its component vaccines is 
contraindicated. The purpose of the two-dose vaccination schedule is to produce 
immunity in the small proportion of persons who fail to respond immunologically 
to one or more of the components of the first dose. (FAQs,2006) 
 
 Use of combined MMR vaccine for both measles doses and all other indications 
should provide an additional safeguard against primary vaccine failures and 
facilitate elimination of rubella and CRS and continued reduction of mumps 
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incidence. Data also indicate that the favorable benefit/cost ratio for routine 
measles, rubella, and mumps vaccination is even greater when the vaccines are 
administered as combined MMR vaccine.(Measles,2006). 
 
  
 
2.7 Adherence  
 
The concept of adherence has been investigated in the context of the Health Belief Model 
(HBM). The HBM has three broad concepts: General health motivation; perception of the 
amount of threat imposed by a specific disease; and, perception of the effectiveness of a 
specific behavior in reducing the threat. Therefore, someone who is positively motivated 
toward health, perceives a disease as a threat, and a particular behavior, such as 
immunization, as threat-reducing, is more likely to engage in that behavior than someone 
who lacks any one of these beliefs (Mirotznik, Ginzler, Zagon, & Baptiste, 1998). An 
individual must also have a psychological state of readiness for action before undertaking 
a recommended health action.  It must be perceived that the individual, in this case the 
child, is susceptible, and the threat is severe and unmodified by barriers and other factors 
to the extent that the parent is motivated to act (Redeker, 1988). The concept of 
adherence is also affected by numerous other factors including knowledge of the need for 
the action or behavior, such as immunizations, past experiences, competing activities, 
cost, and transportation (Wilson, 2000).   
  
2.7.1: Immunization Requirements  
 
West and Koop (2000) pointed out that there are no formal legislative mandates requiring 
complete immunizations by the age of 2, thereby leaving children vulnerable to the 
potentially devastating effects of these preventable illnesses.  
 
 
2.7.2: Immunization Rates  
 
 A National Immunization Survey conducted by MARAM in 2004 found that less than 
70% of 2-year-old children had received all recommended vaccines (MARAM, 2004). A 
more detailed list of rates, by vaccine, estimates that 85-% of children are fully 
vaccinated against diphtheria, tetanus and pertussis.  
 
Although the rates for the individual vaccines are much higher, the rates for the basic 
series are disappointing.  It should be noted that the rates are based on a sample of 1650 
randomly selected 2-year old children in the West Bank and Gaza. The success of 
vaccine coverage in Palestine is attributed the efforts of MOH and UNRWA services.  
 
 Abdeen (2004) reported that the measurement of immunization rates is affected to a 
large degree by mobility of the population and the lack of a coordinated immunization 
tracking system. Because many non-refugee children receive immunizations at various 
clinics and other medical facilities, the rates reported for this population may be 
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inaccurately low. Abdeen et al. (2000) reported that the key issue in immunization 
assessment methodology is defining the patient population. In Palestine, the majority of 
children now receive vaccines through governmental and UNRWA providers. The 
providers that participate in the EPI Program provide aggregate numbers of 
immunizations given. National immunization rates are computed by using data reported 
for all children by all providers. While the data are assumed to be representative of the 
actual populations, it is possible that the true immunization rate for non-refugee children 
is negatively affected by their mobility and the frequency with which they change 
medical providers.  
 
2.7.3: Effects of Poverty and Other Sociodemographics  
 
 In reviewing the literature on the topic of adherence rates for immunizations, it was 
quickly evident that the vast majority of the published studies show poverty and a lower 
overall socioeconomic status to place children at risk for immunization non-adherence. 
Santoli, Szilagyi, and Rodewald (1998) identified five factors strongly linked to low 
immunization rates: socioeconomic factors including poverty and cost; starting 
vaccinations late; a lack of patient and provider awareness of the need for more 
information; provider practices such as missed opportunities and failure to track needed 
immunizations and remind parents when they are due; and, office or clinic factors like 
long waits and inconvenient hours.  
 
Yawn et al. (2000) spoke to family characteristics that have been associated with lower 
immunization rates in 2-year-olds. These include large family size, less formal parental 
education, lower socioeconomic status, being nonwhite, single parent families, receiving 
public health department services, and inadequate insurance. This study, however, found 
many serious barriers to immunization adherence in a non-indigent population as well. 
These findings support the assumption that factors other than indigence play a significant 
role in immunization non-adherence. Examples of these factors are inconvenience, fear of 
reactions, sick child delays, and not knowing the recommended schedule of 
immunizations. Parents commonly suggested the need for a recall system and for a 
unified immunization schedule.   
 
 Several reports indicated that sociodemographic characteristics are linked to 
immunization status.( Prislin, Dyer, Blakely, and Johnson 1998) concluded that 
children’s immunizations are affected primarily by their parents’ beliefs, attitudes, and 
perception of control over immunizations. This conclusion is not consistent with the 
findings of(Strobino, Hughart, & Guyer, 1999). Which indicate that while socio-
demographics are closely associated with immunization status, there is little relationship 
between parents’ attitudes and immunization status? However,( Gellin, Maibach, and 
Marcuse, 2000) indicated that parents frequently have an attitude of indifference. Since 
vaccines have greatly reduced the threat of many serious childhood illnesses, parents may 
now undervalue immunizations. The diseases prevented by vaccines no longer serve as a 
reminder of the importance of childhood immunization (Gellin, Maibach, & Marcuse, 
2000).  
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 The National Immunization Survey conducted by MARAM in 2004 indicated that less 
than 70% of individuals who are the most susceptible to vaccine-preventable diseases, 
children under the age of 2, are fully immunized (MARAM, 2004). Data from URWA 
(2004) documented better over-all immunization rates than the national rates.  
 
  
2.8 Research  
  
Pender’s Model  
Using Pender’s (1996) Model as a framework for studying immunization practices, the 
behavior specific cognitions she identified can be seen in studies that examine perceived 
benefits of, and barriers to, immunization. The qualitative study by Evers (2000) included 
these cognitions. Caregivers sampled (N=13), using focus-group interviews, reported that 
immunizations ―keep our children healthy‖ and protect them from some common 
childhood illnesses. Barriers reported in the study included long waiting times at clinics 
and conflicts with clinic hours and work or school. Despite the small sample in the study, 
interesting commonalities emerged among the four focus groups in response to the same 
open-ended questions asked of each group. None of the caregivers mentioned cost or 
transportation as barriers to obtaining immunizations.  They did include less commonly 
voiced barriers such as caregiver laziness and lack of responsibility for the well-being of 
their children.  
 
 Houseman, Butterfoss, Morrow, and Rosenthal (1997) in another qualitative, focus-
group study of public, military and private sector mothers (N=41) also reported long 
waits as a barrier, in addition to concerns about immunization safety and side effects, 
difficulty reaching the clinic or doctor’s office for appointments, and problems with child 
care, and transportation. This study also included questions to elicit information 
regarding caregivers’ feeling of self-efficacy, another of Pender’s cognitions. The 
respondents reported the perception that health care providers were insensitive in 
communicating with young, inexperienced, and/or poor mothers. The study concluded 
that obtaining optimal; on-time immunizations are a complex task that requires planning 
and resources. To achieve maximum success, the health care system must identify and 
remove barriers, and assist caregivers to maximize opportunities.  
 
 Findings in other studies, including that by Gellin, Maibach, and Marcuse (2000) would 
lead to questions about parents’ self-efficacy when they (25%) reported fears that 
children’s immune systems may be weakened by too many immunizations. This 
nationally representative telephone survey of 1600 parents also reported that a substantial 
minority of respondents (23%) believed that children get more immunizations than are 
good for them. Although most of the parents surveyed understood the importance of 
immunization and supported them (86.9%), many (19 to 25%) had misconceptions that 
could erode confidence in their safety. The study concluded that more education is 
needed to address common misconceptions and ensure informed decisions regarding 
immunizations. It further reported that parents see physicians and nurses as the most 
important source of information about immunizations, further documenting the 
importance of the role of health care providers in reducing this barrier to immunization. 
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Data from this study can be very useful in helping providers and public health officials 
design strategies to better meet the needs of communities and children relative to 
immunization provision.  
 
 Yawn, Xia, Edmonson, Jacobson, and Jacobsen (2000) reported that fear of reactions to 
vaccines was the biggest barrier to obtaining immunizations. They also listed long waits 
as a problem. The population-based, case-control designed study included 332 cases and 
1,053 controls, all parents of under-immunized and fully immunized children, under 20 
months of age. It is note-worthy that in multivariable analysis, there were two significant 
family demographics associated with under-immunization: income and self-payment. In 
the study, conducted in a relatively affluent Midwestern community, 47% of the parents 
reported some barriers to immunization series completion, although less than 3% were 
considered major barriers. Identification of barriers, as indicated by this study, may 
provide useful information on strategies to overcome them.   
 
 
 Interpersonal and situational influences on health promotion, specifically those related to 
immunization adherence, have been examined in numerous studies. Rodewalk et al. 
(1995), in a historical cohort study of 1,178 children, aged 12 to 30 months; found that 
34% were under-immunized at 12 months of age. Compared to fully immunized children, 
the under-immunized group made 47% fewer preventive health visits and was at greater 
risk for delayed screening for anemia (38%), lead (69%), and tuberculosis (76%). They 
also had 50% more missed appointments. The researchers concluded that under-
immunization is a strong indicator of inadequate health supervision in this population. 
The study makes a strong case against uncoupling immunizations and primary care.  
 
 Another type of situational influence was examined by Wilson (2000). Because rural 
areas usually have fewer sources of health care, higher rates of poverty, and a generally 
poorer health status, it would seem logical that the children would have lower 
immunization rates. However, Wilson reported on data that indicated comparable 
immunization rates between rural and urban children. In his study, a grounded theory, 
qualitative analysis of data obtained from 12 subjects (parents), Wilson identified other 
situational influences that contributed to under-immunization, including negative past 
experiences with immunizations, such as adverse reactions, and competing tasks which 
included work schedules and other causes of lack of time to obtain immunizations. The 
study also concluded that maintaining a strong relationship between parents and health 
care providers and providing accurate and timely information are key components to 
improved immunization adherence.  
 
 The aspects of the Health Promotion Model described by these studies clearly indicate 
the applicability of the use of this model in studying immunization adherence and 
comparison of adherence between refugee and and non-refugee children.  
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2.8.1: Immunization Preventable Diseases 
  
 The study by Gellen, Maibach, and Marcuse (2000), cited previously, asked respondents 
to rate the severity of vaccine-preventable diseases.  Meningitis from H Influenza B, 
polio, and hepatitis B were rated the most serious, with pertussis and measles being 
considered somewhat less serious and varicella perceived as the least serious. In the 
study, 87% agreed that immunization is extremely important in keeping children well. 
However, 25% believed that too many immunizations may actually weaken a child’s 
immune system and 23% thought that children get more immunizations than are good for 
them. The study provides valuable insight into parents’ misconceptions regarding 
immunizations and the on-going need for education.  
  
Adherence 
  
 Irigoyen, Findley, Earle, Stambaugh, and Vaughan (2000) found that reminding parents 
that vaccinations are due is an effective strategy for increasing vaccination coverage. In 
their study of 1,273 children, ages 4 through 18 months, patients were assigned to 1 of 4 
groups: a control group who received no intervention (n = 346); a group that received 
post card reminders (n = 314); a group that received telephone call reminders (n = 307); 
or, a group that got both a post card and a telephone call (n = 306). The primary outcome 
variables were kept-appointment rate and vaccination coverage. Children assigned to the 
reminder groups were significantly more likely to keep appointments than controls 
(13.7% higher), with children who received both a post card and a telephone call being 
2.3 times more likely to keep appointments than the controls (95% CI = 1.4, 3.7). The 
reminders were also significantly effective in increasing vaccination coverage for the 
subgroup of children who were not up-to-date at baseline. The study showed that 
appointment reminders are a sensible and cost-effective way to increase kept-
appointment rates, thereby reaching and vaccinating children who are not up-to-date. 
Children who kept their appointments were more than twice as likely to be immunized 
fully for their age. For children who were not up-to-date at baseline, the postcard and the 
telephone reminders tripled their immunization coverage rate compared to controls (OR = 
2.9, CI = 1.1, 8.0). The study by Wilson (2000) corroborates the importance of 
immunization reminders, with 58% of the mothers in that study admitting to confusion 
about the immunization schedule and depending on reminders to know when 
immunizations are needed.  
 
Immunization Rates  
 
 Determination of immunization rates must include specific criteria for inclusion in any 
evaluation of the rate for a specific population. In a study by Perrin et al.  (2000), an 
assessment of immunization rates in 10 pediatric practices was conducted using four 
methods of defining the denominator of active patients. The assessments were done using 
the Clinic Assessment Software Application (CASA) to determine the number of records 
to be assessed in each practice, based on the size of the practice. A total of 1,823 patients’ 
charts were reviewed, 641 from high- Medicaid practices and 1,182 from low-Medicaid 
practices. For all practice types (high- and low-Medicaid), the   mean immunization rate 
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was 83%. The rate in the high- Medicaid group was 71.8%, with the low-Medicaid group 
being 87.8%. The immunization rates were significantly higher in practices that 
frequently purge inactive patients. In the high-Medicaid practices, 61% of the patients 
were considered active, compared to 83% in the low-Medicaid groups. The study also 
concluded that immunization rates reported by County Health Departments and other 
providers with no means of adjusting for patients who leave the area or obtain care 
through alternate providers, understandably, demonstrate lower immunization rates when 
analyzing aggregate data. 
   
(Stokely, Rodewald and Maes, 2001), in a study that analyzed data from the 1995 
National Immunization Provider Record Check Study, reviewed 1,352 records of children 
19 to 35 months of age. From an immunization history questionnaire mailed to and 
completed by parents, 1,352 (65%) had provider immunization data. A total of 304 (22%) 
children went to more than one provider for immunizations. Sensitivity, specificity, and 
predictive value analysis of the most recent provider was performed to determine if the 
ability to identify under-immunized children varied by provider type. They found that 
among children with more than one immunization provider, the records of the most 
recent provider were wrong 23% of the time, indicating that completely vaccinated 
children were in need of additional immunizations. The study affirmed that scattered 
immunization records significantly reduce clinicians’ ability to determine the 
immunization status of their patients, potentially resulting in both over- and under-
immunization. Analysis of the study indicates that a significant number of fully 
immunized children (150,000) are thought to be under-immunized. Numbers of this 
proportion could significantly impact immunization rate data throughout the country.  
  
Effects of Poverty and Other Socio-demographics  
 
Many studies have examined the effects of poverty and other socio-demographics on 
childhood immunization. (Moore, Fenlon, and Hepworth, 1996) in a study of 566 
mother/infant dyads which included interview and immunization record review, 
compared Mexican-American (n = 274) and white, non-Hispanic (n = 292), Medicaid-
sponsored 1-year-olds. Comparisons were made between the two groups using the chi-
square test. Correlations and multiple regressions were used to determine relationships 
between variables such as maternal age (χ
2 
= 2.309; df = 5; p = 0805), number of siblings 
(χ
2 
= 32.999; df = 2; p ≤ .001), maternal education (χ
2 
= 42.376; df = 3; p ≤ .001), marital 
status (χ
2 
=12.575; df = 2; p = .002), employment status (χ
2 
=8.343; df = 1; p = .004), 
travel time (χ
2 
= 17.277; df = 4; p = .002), and the infant’s health status and immunization 
level. Most of the infants, 90.1%, were considered by their mothers to be in good or 
excellent health. The other 9.9% thought their babies were in fair or poor health. The 
mean number of children in the white, non-Hispanic families was 2.33, while the 
Mexican-American families averaged 3.14 children.  More of the white, non-Hispanic 
infants received the basic series of immunizations by 1 year of age (74%) than the 
Mexican-American children (58%). Other variables that correlated with higher 
completion of the basic series were younger maternal age and higher maternal education 
levels.  
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The results of this study are comparable to the results of the analysis by the State of 
Florida, Department of Health (2002) of the immunization status of 2-year-old children 
by high-risk characteristics. Higher maternal education was an indicator for higher 
immunization rates, with 89% whose mothers completed grade 12 fully immunized, 
compared to 78.2% fully immunized whose mothers did not finish high school.  Children 
with more siblings also had lower immunization rates in Florida.  Of those with no 
siblings, 88% were fully immunized compared to 68% who had three or more siblings. 
Greater maternal age, however, in Florida, correlates to higher immunization rates with 
87.9% of children whose mothers were over 30 being fully immunized and 76.4% whose 
mothers were less than 20 having all recommended shots.  
  
2.9 Summary  
  
  A review of the theoretical and research implications of Pender’s (1996) Revised Health 
Promotion Model, with its six behavior-specific cognitions and affects in the promotion 
of behavior change, support its appropriateness as a framework for this study. Identifying 
and analyzing the roles these factors play in parents’ decisions regarding immunizing 
their children provide insight into immunization adherence.  
 
 Vaccines to provide immunization against the 10 diseases, which are currently 
recommended for children, age 2 and below, have significantly reduced morbidity and 
mortality for the diseases (MOH, 2004). Yet, there is no formal legislative mandate that 
all children be immunized by age 2. The literature clearly indicates that many children 
are not adequately immunized and that many factors contribute to immunization non-
adherence, including the methods by which immunization rates are calculated (Perrin et 
al., 2000). While studies have found that poverty is a factor (Findley, Irigoyen & 
Schulman, 1999; Hillman et al., 1999), other studies indicated that factors not related to 
income were as, or more, problematic (Houseman et al., 1997; Wilson, 2000; Yawn et al., 
2000). This study further examines and will ultimately add to the body of knowledge 
regarding factors related to immunization adherence. 
  
 Chapter 3 describes the methodology used for this study. It also presents the design, 
setting, sample size, protection of human subjects, instruments, data collection, and data 
analysis procedures utilized.  
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Chapter Three 
 
Methodology 
  
 This chapter describes the methodology applied to the study. The design, setting, sample, 
protection of human subjects, instrumentation, data collection, and data analysis 
procedures are discussed.  
  
3.1 Study Design   
  
 The study consisted of an ex-post-facto, retrospective review of the immunization 
records of 2-year-old children in the West Bank and Gaza. The independent variable of 
refugee or non-refugee was expected to affect the dependent variable of immunization 
adherence.   
 
The Research Questions examined are: (1) What were the demographic characteristics of 
children from which data was obtained for this study? (2) Are there differences in 
immunization adherence for refugee and non-refugee 2-year-old children in the West 
Bank and Gaza?  
  
3.2 Setting  
  
 The immunization records of 2-year-old children from survey participants were 
examined. The 1997 census conducted by the Palestinian Center of Bureau Statistics was 
used in order to reach a cross section of the geographic locations of the children’s 
residences.  
  
3.3 Survey Design 
 
An area based sampling frame was used with a three stage stratified design consisting of 
a selection of clusters/primary sampling units (PSUs), households within the selected 
clusters/PSU, and selecting the mother and youngest child as respondents within a 
household.  
3.4 Sampling 
As for most surveys, the sample design was influenced by statistical, financial and 
operational considerations. A random sample of 2-year-old child’s immunization records 
was reviewed.  Given that the assumptions specified in the Data Analysis are credible for 
the populations of interest and the researcher’s having set alpha at .05, power (1-β) at .80, 
and a moderate effect, a minimally adequate sample size was determined to be 160 
records each of refugee and non-refugee children (346 total). Every effort was made to 
keep the sample sizes equal in order to prevent reductions in power.    
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3.5 Protection of Human Subjects  
  
The study was conducted following approval by the Ministry of Health Institutional 
Review Board. In conducting the record review, patient confidentiality was protected, to 
the extent allowed by law, at all times. The children’s names were not recorded. Their 
immunization records were copied by field workers specially trained and given to the 
researcher with no identifying information other than a number, which was assigned by 
the staff. Other demographic information, including the child’s date of birth (to verify the 
age), sex, family size and composition, birth order, insurance status, mother’s marital and 
work status, and refugee versus non-refugee status, contained no information that could 
be linked to a specific child. Consent forms were not required since the records were 
anonymous.  
 
3.6 Instruments  
 
The UNICEF tool was available for use in recording immunization and demographic 
information (See Appendix A). It contained the date of birth of each child whose record 
was reviewed as well as an indicator of the refugee eligibility status. The review tool also 
included the list of recommended immunizations that should be obtained by children who 
have reached age 2, and a space for the date of receipt of the vaccine. Children who 
received all of the immunizations, at the appropriate time intervals, were considered fully 
immunized and therefore, adherent. In lieu of the review tool, staff could also provide a 
copy of the child’s immunization record, with no name, an example of which is Appendix 
B, on which they also recorded the other needed information.  
 
3.7 Pilot Testing 
  
The pilot test included the following steps:  
Two-stage pilot testing of the questionnaire was carried out to ensure reliability and the 
highest possible validity. The first pilot was carried out to test the clarity, consistency, 
and relevance of the questions to the mothers who would be surveyed. A second pilot test 
was conducted after final modifications of the questionnaire to ensure that the 
questionnaire was reliable and relevant to the target population.   
1) Two experts who helped in revising the questionnaire reviewed the instruments and 
their notes were taken into consideration. 
2) Pilot testing at the health center level was also done; participants were the staff nurses 
from the Jerusalem Health Center and Amary Health Center.These two centers were not 
included in the survey letter in order to decrees the bias. 
  
3.8 Data Collection 
 
Data collection started on June the first and continued to the 30th of July 2005  
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3.9 Data Entry  
 
In this stage data were entered into the computer using an EpiInfo number 6 data entry 
template. The data entry program was designed to satisfy the following requirements: 
 Duplication of the questionnaire on the computer screen. 
 Logical and consistency checks of data entered. 
 Possibility for internal editing of questionnaire answers. 
 Minimizing of potential errors in digital data entry and fieldwork. 
 User-friendly handling. 
 
 
3.10 Quality Control  
 
Included repeating data collection of at least 5% of the household questionnaires to 
ensure quality and validity of data collection. 
 
At least 5% of the data entered were re-entered to ensure maximum quality of data 
entered.  
 
3.11 Editing, Cleaning and Coding  
 
All completed questionnaires were edited, using the same instruments and coding 
according to the Palestinian Central Bureau of Statistics (PCBS) coding system. A code 
book was developed for the questionnaire to ensure consistency in data entry and to serve 
as the reference for the data base and analysis. 
 
All the home based (child) records and clinical records were recorded by digital camera, 
and saved to the computer to serve as a reference.  
   
3.12 Data Analysis  
  
 Research Question 1 (What are the demographic Characteristics of children from which 
data will be obtained for this study?) was examined by using and presenting descriptive 
statistics including central location measures, dispersion measures, and displays of  
frequency such as graphs, charts, plots, etc. Both the arithmetic mean and the median are 
provided to describe the central location of the data for variables that are measured on at 
least an interval scale. The median is the more representative central location measure 
since, under conditions of asymmetry, it is unaffected by extreme scores in a data set 
(Thorndike & Dinnel, 2001).  
 
 To describe the general dispersion of scores from the mean, variance and standard 
deviation are provided. Again, because a scale of measurement that is at least interval is 
needed for meaningful interpretation of these statistics, the investigator only presents 
these summaries when that condition is reasonably defensible.  
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 For Research Question 2 (Are there differences in immunization adherence for refugee 
and non-refugee 2-year-old children in the West Bank and Gaza?) the primary analytical 
and inferential aspect of the inquiry is the need for a statistical inference regarding the 
difference, if any, in immunization adherence rates for refugee and non-refugee 2-year-
old children in the West Bank and Gaza. Since the children in the study are either be up-
to-date or not with regard to immunizations, the data are dichotomous. The primary 
independent variable of refugee or non-refugee is also dichotomous.  Therefore, data are 
considered nominal in scale. This research question was addressed through the use of two 
analogous, independent sample techniques, the traditional Chi-square test for a 2 X 2 
contingency table with a correction for continuity, and the Fisher Exact test (Conover, 
1971). Although these two techniques make the same assumptions (the observations both 
within and between the samples are independent; the four cells in the contingency table 
are mutually exclusive and exhaustive; the underlying nature of the dependent variable is 
continuous; the samples are drawn randomly) and test the same null hypothesis, the first 
test gives an approximate p value and the second provides an exact p value for the 
statistical outcome. While both were determined for comparison purposes, the 
conclusions of the study result from the p value provided by the Fisher Exact procedure.   
 
The null hypothesis (H
o
) is that there is no difference in immunization adherence for 
refugee and non-refugee 2-year-olds in the West Bank and Gaza. Another way to state 
the null is that the two samples are selected from the same population. The alternate 
hypothesis (H
a
) is that there is a difference in the immunization adherence rates for these 
groups of children. This can also be stated that the two samples are drawn from two 
different populations.   
  
3.13 Summary  
  
 This chapter described the methodology applied to the study, which compared 
immunization adherence rates of refugee 2-year-old children to those of non-refugee 2-
year-old children. The design of the study is described, as are the setting, sample size 
determination, protection of human subject’s information, instruments, procedure, and 
data analysis. The ex-post-facto, retrospective review of randomly chosen immunization 
records from households in the West Bank and Gaza was described. The sample of 173 
each refugee and non-refugee children’s records are included and analyzed using 
descriptive statistics and two independent sample techniques. The null and the alternate 
hypotheses are described. Analysis of the data will be presented in Chapter 4.  
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Chapter Four 
Analysis and Findings 
  
  This Chapter presents the statistical findings of the study. Data describe the 
demographic characteristics of the sampled population (Research Question 1) and address 
the answer to Research Question 2, determining if there are differences in immunization 
adherence for refugee and non-refugee 2-year-old children in the West Bank and Gaza.    
  
4.1 Demographic Description of the Sample  
  
 The randomly selected immunization records of 346 2-year-old children residing in the 
West Bank ad Gaza, refugee, 50% (n = 173), and non-refugee, 50% (n =173), settings 
were reviewed. The gender of the children was almost evenly divided with (n=178; 
51.4%) males and (n=168; 48.6%) females equally divided between the West Bank and 
Gaza.  
 An attempt was made to determine the number of siblings and the birth order of each 
child in order to analyze the possible correlation between immunization adherence and 
those factors.  
 
Table 4.1 presents the number of siblings of each child whose record was 
examined.   
  
            Table 4.1 Number of Siblings, Siblings Frequency, Percent Valid Percent    
  
Number of 
Sibling 
Siblings  Frequency Percent Valid Percent 
0 8 2.3 
1 22 6.4 
2 25 7.2 
3 10 2.9 
4 16 4.6 
5 27 7.8 
6+ 238 68.8 
Total 346 100 
 
Of the children’s records (n = 346) from which information regarding siblings could be 
obtained, 2.3% (n = 8) had no siblings, while 28.9% (n = 100) had from 1 to 4 brothers 
and/or sisters. The majority had 68.8 percent; n= 238 of the 2-year-old children had six 
and more siblings. We expected that as the number of siblings increased to 2, 3, and 4, 
the number fully immunized decreased to 66.7% (n = 8), 57.1% (n = 4), and 44.4% (n = 
4) respectively, leading to the conclusion that the families with multiple children who 
were sampled were less adherent with immunizations which was not the case for five 
91.7 % (n = 11) and for six plus siblings (61%; n= 72) respectively.  
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       Figure 4.1 Birth Order Frequencies, Percent Valid Percent   
 
 
Of the first, second and third-born children whose records were sampled, 66% (n = 16) 
were fully immunized. In the 4 - 5 and 6 -7 -born groups, 65% (n = 43) and 52.6% (n = 
20) respectively were completely adherent. The data, therefore, indicate that 
immunization adherence decreased as the order of birth increased. However, the rate of 
adherence was higher for the 8 plus-born group, 62.5% (n = 30). 
 
The data revealed that the percentage of mothers who had finished secondary school and 
above were 37.6% (n = 130) while 35.8% (n = 124) had finished preparatory school. 
Only 1.7% (n = 6) had no education.  
 
The number of refugee (n = 173) and non-refugee (n =173) children in the sample was 
virtually even. The children with UNRWA medical care, therefore considered refugee, 
comprised 50%, while 50% had private or governmental health care coverage, making 
them considered non-refugee.   
  
4.2 Results  
  
The study examined a total of 346 immunization records of 2-year-old children to 
determine if they were fully immunized for the required specific diseases.  
 
To be considered fully immunized, the records had to contain documentation of sixteen 
antigens according to the list of vaccination doses.  
 
The total number of children in the study who received all of the required vaccines was 
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58.8%. Of the 80 children who were not fully immunized, 58.1% (n = 36) were refugees 
and 59.1% (n = 44) were non-refugees. Table 3 shows the frequency and percentage of 
children who were immunized for each vaccine:  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.  Percentage of children up-to-date at age 2 years, by type of vaccination, 
according to mother recall, vaccination cards and medical records (vaccination card 
subset; n = 346). 
 
MMR and TOPV accounted for the largest number of missed doses. The percentage 
coverage was (74.3% and 74.4% respectively. This is not unexpected since they were two 
of the vaccines in critically short supply during the study period.  
 
The next largest number of missed doses was DPT4 vaccine with percentage coverage of 
79.5%. 
 
Figure 4.3 provides a comparison of adherent refugee and non-refugee children and the 
exact p value for each specific type of vaccine. To determine the statistical significance, 
if any, between immunization adherence for refugee and non-refugee children, the Fisher 
Exact Test was used. The exact p value for refugee and adherence was p = .034, a 
significant difference from Alpha, which was set at .05, leading to the conclusion that the 
sample data was sufficient for the claim that refugee and immunization adherence are 
independent of each other. The null hypothesis, there is no difference in immunization 
adherence between refugee and non-refugee children, must be accepted.  
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Figure 4.3 Number of Adherent Refugee and non-refugee By Vaccine Type  
 
 
4.3 Conclusions  
  
 The following conclusions are drawn from analysis of the data:  
1. No statistical significance difference was detected in terms of immunization 
coverage between females and males.  
2. There was no clear association between immunization coverage and number of 
siblings as well as birth order for both refugee and non-refugee children.  
3. No statistical significance difference was detected in terms of immunization 
coverage between refugee 2-year-olds and non-refugee.  
4. MMR Vaccine accounted for the greatest number of missed doses, with TOPV 
and DPT4 ranking second and third respectively.  
 
  
4.4 Summary  
  
 This chapter provided the statistical findings to describe demographic information 
regarding the sample studied and to determine if there are differences in immunization 
adherence between refugee and non-refugee 2-year-old children who reside in the West 
Bank and Gaza. In the sample studied, there was no significant difference in adherence 
rate between refugee and non-refugee children. A discussion of factors that could have 
had an effect on the outcome of the study will be presented in Chapter 5.  
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 Chapter Five  
Discussion 
 
The value of immunizations to the public health of this and future generations is rarely 
disputed. However, the number of fully immunized children in the West Bank and Gaza 
is far from optimal and it is declining. Historically, studies of immunization adherence 
have focused on barriers and missed opportunities. One barrier often targeted as a reason 
for low adherence is occupation (MARAM, 2004). This study was designed to look again 
at refugee and non-refugee 2- year-old children to determine if indigence is a factor in 
immunization adherence in the West Bank and Gaza. The data from the study show that a 
number of non-refugee children are not fully immunized, and they significantly exceed 
the number of refugee, non-immunized children.  
  
This chapter will discuss the findings of the study and possible trends related to them. It 
will relate the findings to both supportive and differing literature and tie the results of the 
study to the conceptual framework used as a guide for the research. Limitations will be 
presented and reviewed. The relationships of assumptions to the outcomes of the study 
will be examined, as will recommendations for future research. Implications of the study 
for nursing practice, including advanced practice, administration, and education, will also 
be presented.  
  
5.1 Findings  
  
The results of this study, that refugee 2-year-old children have similar rates of 
immunization adherence to non-refugee 2-year olds in the West Bank and Gaza, were not 
unexpected, given the resources available for immunizing children in the area. UNRWA 
medical programs offer refugee children a medical home and preventive care. This trend 
is expected to continue unless the resources to fund the Program are seriously reduced or 
eliminated.   
  
5.2 Relationship to Literature  
  
The literature reviewed for this study contained numerous findings and opinions 
regarding the effect of socioeconomic status on immunization adherence. Some studies 
cite parental attitudes and beliefs as a barrier to immunization adherence (MARAM, 
2004). The findings of this study clearly correlate with the studies that cited barriers 
irrespective of refugee status as the cause for under-immunization.  
  
5.3 Conceptual Framework  
  
Using concepts from Pender’s (1996) model as a guide for this study was useful in 
determining the scope of the data elements needed to draw conclusions about the 
population and their parents. The effect of refugee on parents seeking immunizations for 
their children is tied to the behavior-specific cognitions. Since over 58% of all children 
whose records were reviewed were fully immunized, most parents apparently perceived 
that immunizations have positive consequences and are beneficial for their children. 
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These positive feelings may have led to the parents’ feeling good about themselves as 
they overcame negative interpersonal influences, such as bad past experiences, inaccurate 
information, and numerous barriers and hardships making immunization adherence 
difficult. Real, or imagined, obstacles to immunization adherence may be linked to family 
income, transportation issues, working mothers with many competing demands, and other 
family dynamics (MARAM, 2004). In this area, as evidenced by this study, the health 
promotion behavior of low-income families, specifically in obtaining immunizations for 
their children, significantly exceeds that of non-refugee parents.  
The hypothesis of this study, that refugee is not a primary influence on immunization 
non-adherence for 2-year-olds in the West Bank and Gaza, was supported by this study.  
 
Pender (1996) advocated nursing intervention to reduce barriers to health care and 
overcome cultural influences that restrict access to care. She encouraged empowerment 
of individuals to value health and the benefits of health-promoting behaviors to such an 
extent that they are willing to overcome barriers to healthy behaviors. In the West bank 
and Gaza, many refugee children have the benefit of a nurse-case managed, UNRWA 
medical care program, that helps to reduce barriers and to empower parents to obtain 
health care, including immunizations, for their children. Although the usual barriers to 
immunization exist, in the West Bank and Gaza, they seem to have a greater effect on the 
non-refugee population than on the refugee.  
 
One aspects of Pender’s model were utilized in determining key data elements obtained 
in the study. Assessing elements such as urban versus rural dwelling, maternal marital 
status, number of siblings, and birth order, targeted interpersonal influences and 
immediate competing demands. These are key components of Pender’s model and 
provided insight into the characteristics of the population studied and their families.   
 
 Another unexpected finding was that more non-adherent children reside in urban areas. 
Logistically, it would seem that immunization adherence would be more difficult for 
children residing in rural areas. The fact that parents often commute to the urban 
locations for work and for day care for their children, it is likely that they also commute 
for medical care. This assumption is validated by the fact that there are few pediatric 
medical care providers in the rural areas. It is possible that having to expend more effort 
to obtain immunizations makes the availability of the care more appreciated by the non-
urban parents, resulting in greater adherence. Conversely, those who have the service 
readily available and who have to expend little effort to obtain immunizations may 
undervalue their worth and underutilize the services.  
 
 The influence of the number of siblings and birth order of the children whose records 
were reviewed is also interesting. Children with higher numbers of siblings adherent and 
those who were fifth or more child born in the family were reasonably  adherent. These 
findings may indicate that parents become less concerned with immunization as the size 
of the family increases. However, they could also validate that larger families result in 
more competing demands for parents’ time, making immunization adherence a lower 
priority.  
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The use of Pender’s (1996) model as the framework for this study provided good points 
of reference for examining immunization adherence. With adherence as the target, Figure 
1, Target:  Immunization Adherence depicts the influence of individual characteristics 
and experiences, including prior experiences, on perceived benefits, barriers, and self-
efficacy. It shows that the influence of family and other support systems, providers, 
peers, role models and the norms of the community have an effect on reaching the 
ultimate goal of adherence. It also shows that competing demands affect all levels of 
activity in route to attaining the target, immunization adherence.   
 
 Relating the behavior-specific cognitions, as well as interpersonal and situational 
influences, on health promotion, described by Pender, to parents’ actions in obtaining 
immunizations for their children worked well and provided interesting supportive 
information. The data indicate that efforts to increase immunization adherence in the 
West bank and Gaza should focus on non-refugee, urban dwelling, later-born children, 
with employed mothers, would potentially render the greatest impact.  
 
5.4 Assumptions  
  
The assumptions presented in Chapter 1 were neither supported nor unsupported by this 
study. The argument could be made that the first assumption, all parents want their 
children protected from preventable illnesses, was supported, given the number of 
children shown by the study to be adherent with immunization recommendations. 
However, it is not possible to state that non-adherence correlates to parents’ wanting their 
children to contract illnesses. Rather, barriers and competing demands may outweigh the 
risk of illness, sadly forcing parents to gamble with their children’s health and well-
being.  
 
 An unstated assumption of the study was that there would be an adequate supply of 
vaccine available for all children seeking immunizations. Unfortunately, this is no longer 
a valid assumption. In recent years there have been critical shortages of MMR, Hib, and 
Hepatitis B vaccines, resulting in children’s missing doses (MARAM, 2004), and 
creating an unanticipated limitation to the study.  
 
5.5 Limitations  
  
 In addition to the limitation stated in Chapter 1, there were several others that presented 
during the course of the study. There is no standard form or format for recording 
immunizations in primary health care clinics. Even within the clinics, multiple formats 
are used, and almost all of the records are hand-written, making reviewing and recording 
the data very arduous. However, the reliability of the data collected is thought to be very 
high. None of the offices used the tracking form developed for this study, opting instead 
to provide copies of immunization records. Having copies of the actual records placed 
responsibility for recording the data solely on the researcher, leaving no concern for the 
possibility of the doctors’ staff making errors.   
The geographic area within which this study was conducted is heavily penetrated by 
health providers for both the refugee and the non-refugee population.  
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Vaccine shortages and the necessity of postponing doses of vaccine resulted in delay of 
this study until the major shortage was over. And, it is likely that the shortage did affect 
the outcome of the study in that one of the vaccines most frequently missing in non-
adherent children’s records was MMR.  
 
 
5.6 Implications for Nursing  
  
The implications for nursing that result from this study include the need to place renewed 
emphasis on barriers to immunizations that affect not just refugee, but non-refugee 
families as well. Nurses working in public health and UNRWA primary care settings 
must focus on ways to make vaccines readily available to all children irrespective of 
curfews and closures imposed by the occupation.   
  
5.6.1: Clinical Expert/Advanced Practitioner  
 
Advanced practice nurses, working, as clinical experts in pediatric offices, must take the 
lead to redefine the norm in the provision of pediatric well and preventive services and 
make the care available at times that will accommodate the difficulties created by 
occupation. The office-based clinical experts also must address the reduction of missed 
opportunities to immunize children in their practices by keeping abreast of the most 
current recommendations regarding contraindications to immunizations. All nurses 
working in primary care settings must work to assure that opportunities to immunize 
children are maximized by reviewing immunization records at all primary care visits, and 
immunizing children at every opportunity rather than just during scheduled well care 
visits.  
 
5.6.2: Administration  
 
Nurse administrators have the duty and responsibility for development and 
implementation of practice standards for many of the public and private entities that 
provide childhood immunizations. Although case management to help ensure adherence 
to immunization recommendations works, it has a price tag that some think is too high. 
Program administrators must assess the cost-benefit of case management or other 
strategies to increase immunization adherence, such as appointment reminders, after-
hours clinics, etc. Comparing the costs of prospective initiatives to that of morbidity, 
disability, lost parental work time and, therefore, income, and even death due to vaccine-
preventable illnesses may yield data to show that the cost is not too high.  
  
   
5.6.3: Education  
 Nurse educators are key participants in the effort to improve immunization adherence. 
Nursing curricula at both the undergraduate and graduate levels must include emphasis 
on all preventive care, starting with well child services and immunizations. Teaching 
nurses to recognize barriers to immunization and strategies to ameliorate them are 
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paramount to increasing adherence. Teaching the principles of immunology and ways to 
translate the immune response produced by vaccines to parents, in terms they can 
understand, will address one of the major barriers, parental misunderstanding of how 
vaccines work (Yawn  et al., 2000), and encourage them to have their children 
immunized.  
 
Continuing education aimed at office nurses and pediatric nurse practitioners regarding 
vaccine recommendations and strategies for overcoming barriers is needed. Vaccine 
manufacturers invest large amounts of money in professional education programs and 
materials. They are forced to compete for nurses’ and physicians’ time in order to give 
them the resources they have available. Making the information and continuing education 
offerings available at convenient times and in appealing locations will likely result in 
greater utilization.  
  
5.7 Recommendations for Future Research  
  
This study supports the hypothesis that efforts to increase immunization adherence in the 
West bank and Gaza should focus on non-refugee children. However, it is not likely that 
the results of one study will convince policy-makers to change their strategies for 
reaching children who are not adequately immunized.   
 
 
5.8 Summary  
  
A comparison of immunization records of refugee and non-refugee 2-year-old children 
residing in the West Bank and Gaza revealed that non-refugee children were not 
significantly less adherent than non-refugee children. Health-promotion behaviors and 
efforts to overcome barriers by the parents of non-refugee children must be improved 
through education and interventions to make immunizations more readily available. 
Health care providers, including advanced practice nurses, administrators, and educators 
have a role in achieving this goal.   
 
Children do not get a choice in the parents who receive them. The priorities of most 
parents include the best interests of their children, but competing demands for parental 
time, energy, and resources may delay or derail children’s needs, especially those that are 
not crisis-oriented. Fortunately, the failure to obtain immunizations in a timely manner 
does not frequently result in a crisis. But, if and when it does, children suffer needless 
pain, disability, and even death. The efficacy of immunizations is scientifically proven 
and well documented. Vaccines are available to all children, regardless of parents’ 
insurance status or ability to pay. Accepting excuses and allowing children to remain 
unprotected from vaccine-preventable illnesses must stop. Children deserve nothing less.  
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كان العمر أقل من 
سنة 
   لا أعرف89
 |_____|_____| |___|___|___|___|  /  |___|___| / |___|___| |_____| |_____|  10
  20
 |_____| |_____|
  /  |___|___| / |___|___|
 |___|___|___|___|
 |_____|_____|
  30
 |_____| |_____|
  /  |___|___| / |___|___|
 |___|___|___|___|
 |_____|_____|
  40
 |_____| |_____|
  /  |___|___| / |___|___|
 |___|___|___|___|
 |_____|_____|
  50
 |_____| |_____|
  /  |___|___| / |___|___|
 |___|___|___|___|
 |_____|_____|
  60
 |_____| |_____|
  /  |___|___| / |___|___|
 |___|___|___|___|
 |_____|_____|
  70
 |_____| |_____|
  /  |___|___| / |___|___|
 |___|___|___|___|
 |_____|_____|
 يوضع دائرة حول رقم سطر الطفل الذي يقل عمره عن سنتين
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  يتم استيفاء بياناتيا عن الزوج والزوجة70RH-11RHالأسئمة 
 
 A70RH
 80RH
 
 11RH 01RH 90RH
  )الاسم(هل  الاسم
 
 
 
يعيش معكـ في  .1
الأسرة 
متوفي  .2
 معتقؿ .3
 يعيش خارج  .4
 المنزؿ
 يعيش خارج الوطف .5
ما هو المستوى 
  )الاسم(التعليمي لـ 
 
 
أمي  .11
ممـ  .21
 ابتدائي .31
 اعدادي .41
 ثانوي .51
 دبمـو متوسط .61
 بكالوريوس .71
 دبمـو عالي .81
 ماجستير .91
 دكتوراه .02
ما ىي العلاقة بقوة العمل لـ 
 )الاسم(
 
 ساعة 41-1مشتغؿ مف  .1
  ساعة فأكثر51مشتغؿ  .2
 متعطؿ سبؽ لو العمؿ .3
 متعطؿ لـ يسبؽ لو العمؿ .4
 طالب متفرغ لممدرسة .5
 متفرغ لأعماؿ المنزؿ .6
 عاجز عف العمؿ .7
لا يعمؿ ولا يبحث عف  .8
 عمؿ
 أخرى .9
 
 )الاسم(ما ىي مينة 
نوع العمل (المينة الرئيسية 
. الذي يقوم بو الاسم
يسأل اذا كان الفرد مشتغلا أو 
 متعطلا سبق لو العمل
 10مدير 
 20متخصص 
 30موظؼ 
  40مزارع
 50ميني 
 60عامؿ 
 70عاطؿ عف العمؿ 
 80رب منزؿ 
 90عاجز عف العمؿ 
المينة                      
 الرمز
 |_____| |_____| |_____| |_____| الزوج
 |_____| |_____| |_____| |_____| الزوجة
 )المطاعيم(استمارة الطفل : القسم الثاني
يتم جمع بيانات حول جميع الأطفال الذين تتراواح أعمارىم أقل من سنتين والمقيمين مع الأسرة، وفي حال وجد  
. )استمارة لكل طفل(أكثر من طفل مؤىل يتم استخدام استمارة اضافية 
اسم الطفل من قائمة افراد  10HC
 الاسرة
 ــــــــــــــــــــــــــ
 )اسم الطفل(تاريخ ميلاد  20HC
 ـــــــــــــــ/ــــــــ/ـــــ
 )اسم الطفل(جنس   30HC
 |_____|أنثى                                 . 2ذكر           . 1
اسم (ىل سبق وتمقى  40HC
أي نوع من   )الطفل
 المطاعيم؟
 |_____|)                       60HCانتقل الى سؤال (نعم    . 1
 لا ، لم يتمق مطمقا ً. 2
 95 
اسم (لماذا لم يتمق  50HC
 أي مطعوم؟ )الطفل
 
يجب الاجابة عمى جميع 
الخيارات 
 
 نعم. 1
 لا. 2
 عدـ توفر المطعـو .1
. عدـ المقدرة لموصوؿ الى مكاف الخدمة .2
 .مرض الطفؿ .3
ليس لدى /عدـ المعرفة بجدوؿ المطاعيـ .4
 .الأـ الخبرة الكافية
 .وجود مخاطر طبية .5
 .الخوؼ مف الآثار الجانبية لممطعـو .6
صغر (ليس الوقت المناسب لممطعـو  .7
 .)سنو
 .المطعـو غير ضروري أو غير ىاـ .8
 حددي ػػػػػػػػػػػ/أخرى .9
 .|_____|1
 .|_____|2
 .|_____|3
 .|_____|4
 .|_____|5
 .|_____|6
 .|_____|7
 .|_____|8
 .|_____|9
 )اسم الطفل(ىل لدى  60HC
 بطاقة تطعيم؟
 نعـ، شوىدت .1
نعـ، لـ تشاىد  .2
 لا .3
 |_____|
اذا كانت الاجابة في سؤال  70HC
 لا، اسأل عن 70HC
 السبب؟
 لـ يتـ اعطاء الأـ بطاقة .1
البطاقة مفقودة  .2
  ـــــــــأخرى .3
 |_____|
 06 
بالرجوع لبطاقة العيادة وبطاقة الطفل البيتية تسال الأم عن كل طفل مؤىل عمى حده : جدول المطاعيم: 80HC
حول التالية، استخدم بطاقة العيادة و بطاقة الطفل لمتوثيق الصحيح للأسئمة أدناه 
 A نوع المطعوم
ىل تمقى 
الطفل اسم 
المطعوم 
حسب ذاكرة 
الأم 
 
 
 
 
 llaceR
 B
اذا كانت الاجابة 
نعم، ىل تمقى الطعم 
في الوقت المناسب 
 أسابيع 4ليس بعد (
 )المحددمن الموعد 
حسب كرت الطفل 
 drocer dlihC
 2B
اذا كانت الاجابة 
نعم، ىل تمقى 
الطعم في الوقت 
ليس (المناسب 
 أسابيع 4بعد 
من الموعد 
 )المحدد
 حسب كرت
العيادة 
 
 
 
 lacinilC
 drocer
 
 C
، سجل تاريخ تمقي 
 .ومعالمط
سجل التاريخ 
في حال كان  )99(
تاريخ المطعوم 
. غير مسجل
في  )00(سجل 
حال كان اسم 
المطعوم غير 
مسجل 
السطر الأول )1
لبطاقة الطفل 
السطر الثاني )2
 .لبطاقة العيادة
 D
 .السبب في عدم تمقي المطعوم
دون رقم السبب من القائمة 
المرفقة لديك أو من سؤال 
يمكن اختيار أكثر من .  50HC
 سبب
نعـ      . 1 
 لا. 2
 لا اعرؼ. 3
نعـ           . 1
 لا. 2
 لا اعرؼ. 3
نعم .1
لا .2
 لاأعرف.3
  
، حقنة تعطى في GCB مطعوم . 0
.  الكتف خلال أيام معدودة من الولادة
 ينتج عنيا ندبو
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، يعطى بعد الولادة )1(BH .1
 .مباشرة  من خلال حقنة في الفخذ
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، حقنة ضد الشمل )1( VPI. 2
تعطى في الشير الأول من عمر 
 الطفل
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، حقنة تعطى في )2(BH. 3
الفخذ، تعطى في الشير الأول من 
 العمر
 
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
حقنة / ، تطعيم ثلاثي)1( TPD .4
 في الفخذ، تعطى في عمر شيرين
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، حقنة تعطى في )2( VPI. 5
 اعمى الذراع، تعطى في عمر شيرين
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
 16 
، نقط تعطى في )1( VPO.  6
 الفم، تعطى في عمر شيرين
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، تطعيم ثلاثي في )2( TPD. 7
  شيور4الفخذ، تعطى في عمر 
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، نقط في الفم، )2( VPO. 8
  شيور4تعطى في عمر 
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، حقنة تعطى في )3( TPD.  9
  شيور6الفخذ، تعطى في عمر 
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، نقط في الفم، )3( VPO. 01
  شيور6يعطى في عمر 
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، حقنة اخرى تعطى )3( BH.  11
 6في الفخذ الاخر، تعطى في عمر 
 شيور
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
 مطعوم الحصبة، يعطى من . 21
يعطى .  خلال حقنة في أعمى الكتف
  شيور9في عمر 
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
، TPDجرعة منشطة من . 31
 حقنة تعطى في الفخذ
ـــــ /ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 
 |_____|   |_____|
 |_____|   |_____|
 جرعة مدعمة من شمل الأطفال .41
، تعطى نقط في الفم، VPOT
  شير21تعطى في عمر 
 ـــــ/ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
 26 
، RMM جرعة مدعمة من .51
حقنة تعطى في اعمى الذراع، تعطى 
  شير51في عمر 
ـــــ /ـــ/ـــ |_____| |_____| |_____|
 
 ـــــ/ـــ/ـــ
 
 |_____|   |_____|
 |_____|   |_____|
 
اضافة الى المطاعيم التي تم ذكرىا  90HC
جرعات  )اسم الطفل(أعلاه، ىل تمقى 
اضافية من نقاط مطعوم شمل الأطفال 
 و مطعوم الحصبة/أو )VPOT(
نقاط مطعـو شمؿ . 1
 ).VPOT(الأطفاؿ
لا         . 2نعـ     . 1
 |_____|
 ػػػػ/ػػ/اذا نعـ، حدد التاريخ  ػػ
ػػػػ /ػػ/ػػ
 ػػػػ/ػػ/ػػ
لا         . 2نعـ     . 1 مطعـو الحصبة. 2
 |_____|
 ػػػػ/ػػ/اذا نعـ، حدد التاريخ  ػػ
ػػػػ /ػػ/ػػ
 ػػػػ/ػػ/ػػ
اسم (ىل تمقيت استشارة حول تطعيم  01HC
 ؟)الطفل
 نع ـ.1
 )61HCانتقؿ الى(لا .2
 
 |_____|   
 36 
 
 من قدم لك المشورة حول تطعيم طفمك؟ 11HC
 يجب الاجابة عمى جميع الخيارات: 
 
نعـ . 1 .1
 لا. 2 .2
 .طبيب عاـ .1
 .طبيب مختص .2
طبيب نساء  .3
 وتوليد
 طبيب أطفاؿ .4
 قابمة .5
 ممرضة .6
 عاممة صحية .7
 الأصدقاء .8
 لا تذكر .9
 لا أعرؼ .01
حددي /أخرى .11
 ػػػػػ
 .|_____|1
.|_____| 2
.|_____| 3
.|_____| 4
.|_____| 5
.|_____| 6
.|_____| 7
.|_____| 8
.|_____| 9
.|_____| 01
 .|_____|11
في أي وقت تمقيت مشورة حول تطعيم  21HC
 طفمك؟
 يجب الاجابة عمى جميع الخيارات: 
 
  لا. 2نعم         . 1
 
خلاؿ تمقي  .1
الرعاية أثناء 
 .الحمؿ
خلاؿ زيارة  .2
العاممة الصحية 
 لمبيت
خلاؿ زيارتي  .3
 .لتطعيـ الطفؿ
عندما حصمت  .4
عمى برنامج 
 .التطعيمات
خلاؿ ندوات  .5
التثقيؼ الصحي 
 في العيادة
 حددي ػػػػػػػػ/أخرى .6
 
 
 
 .|_____|1
.|_____| 2
.|_____| 3
.|_____| 4
.|_____| 5
.|_____| 6
 
ىل كنت مرتاحة وأنت تسألين مقدم الخدمة  31HC
 ؟)اسم الطفل(الصحية حول تطعيم 
 نعـ .1
 لا .2
 
 |_____|
اذا كانت الاجابة نعم، ىل تمقيت اجابة  41HC 
 مفيدة لسؤالك؟
 نعـ، الى حد  .1
 كبير
 نعـ، الى حد  .2
 .اـ
  غير متأكدة .3
  لا .4
 
 |_____|
 
 
 46 
في أي من المواضيع التالية  A51HC
والمتعمقة بالتطعيم تم 
نقاشيا معك أثناء الزيارة 
الأخيرة لمركز التطعيم 
؟ )اسم الطفل(لتطعيم 
أىمية التطعيم  .1
أىمية أخذ المطعوم في  .2
 وقتو
 جدول المطاعيم .3
 الآثار الجانبية لممطعوم .4
وقت الزيارة لممطعوم  .5
 التالي
التحويل اذا لزم /المتابعة .6
 الأمر
المخاطر في عدم متابعة  .7
 التطعيمات
 موانع إعطاء التطعيم .8
 ـــــــ حددي/أخرى .9
 
 
لا . 2نعـ         .  1
 
 
 
 
 
 .|_____|1
 .|_____|2
 .|_____|3
 .|_____|4
 .|_____|5
 .|_____|6
 .|_____|7
.|_____| 8
 .|_____|9
مقابؿ كؿ اجابة نعـ، اختار 
سؤاؿ رقـ مقدـ المشورة مف 
 11HC
 
 
 
 
 
 
 .|_____|1
 .|_____|2
 .|_____|3
 .|_____|4
 .|_____|5
 .|_____|6
 .|_____|7
.|_____| 8
 .|_____|9
ىل تمقيت أي مواد تثقيفية ليا علاقة  B51HC
أثناء تمقي  )اسم الطفل(بتطعيم 
 الاستشارة أو بعدىا؟
 نعـ .1
 لا .2
 لا أذكر .3
 |_____|
 
نعـ إلى حد ما . 2 نعـ إلى حد كبير . 1 ىل كانت مفيدة؟ C51HC
غير مفيدة . 3
 
 
 |_____|
 
خلال زيارتك الأخيرة لمركز التطعيم،  61HC
ىل تمقيت في أي من المواضيع 
اسم (التالية مشورة حول رعاية 
 ؟)الطفل
 
 
 
 
 
 
 
  نعـ .1
 لا .2
 لا اعرؼ   .3
لا ينطبؽ  .4
 
 
مقابؿ كؿ اجابة نعـ، اختار 
رقـ مقدـ المشور مف سؤاؿ 
 11HC
 |_____| |_____|  الصحي وضع الطفل .1
 56 
السؤال حول ىل تمقى الطفل  .2
 تتعارض مع التطعيمأي أدوية 
 |_____| |_____|
السؤال حول وجود أي أمراض  .3
 |_____| |_____| مثل السرطان وأمراض الدم
السؤال فيما اذا يعاني الطفل من  .4
من الطعام، البيض، (حساسية أم لا 
 )المطعوم
 |_____| |_____|
 |_____| |_____| فحص درجة حرارة الطفل .5
 |_____| |_____| أخذ وزن الطفل .6
 |_____| |_____| أخذ طول الطفل .7
 |_____| |_____| تقديم نصائح .8
 |_____| |_____| اعطاء وقت الزيارة القادمة .9
السؤال فيما اذا يعاني الطفل  .01
 من اسيال
 |_____| |_____|
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 66 
 
 
 
 
 
 
 
  
كم من الوقت انتظرت في الزيارة  71HC
 الاخيرة؟
|___|  الوقت بالدقائؽ
|___||___|  
 دقيقة
 قصيرة. 1 وقت الانتظار؟كيف تصفين  B71HC 
 معقولة. 2
 طويمة نسبيا ً. 3
 طويمة جدا ً. 4
 |_____|
 
عيادة  /ىل استخدمت أكثر من جية 81HC
 ؟)اسم الطفل(لتطعيم 
 نعـ .1
 لا .2
 غير متأكدة .3
 |_____|
 
ىل قمت بتغيير الجية التي طعمت  91HC
 ؟)اسم الطفل(  عادة فييا
 نعـ .1
انتقمي الى سؤاؿ (لا .2
 )52HC 52HC
 |_____|
 
 نعم، 91HCاذا كانت الاجابة في  02HC
حدد الأسباب وراء تغيير جية 
 التطعيم؟
 
 اختار السبب الرئيسي
 عدـ توفر المطعـو  المطموب .4
 عدـ المقدرة عمى دفع الرسـو .5
 منع التجوؿ/الاغلاؽ .6
 تغير عنواف الأسرة .7
 تـ افتتاح مركز جديد .8
 جودة الخدمة غير مرضية .9
عدـ ملائمة ساعات عمؿ  .01
 المركز
 فقداف بطاقة التطعيـ .11
 لـ يتـ استقبالي بشكؿ جيد .21
 الخدمة متوقفة .31
 حدد  ػػػػػػ/أخرى .41
 |_____|
 
ىل سبق وأن فقدت أي جرعة من  12HC
 )اسم الطفل(المطاعيم ل 
 نعـ .1
انتقؿ الى سؤاؿ (لا  .2
) 32HC
 لا أعرؼ .3
 
 |_____|
اذا كانت الاجابة نعـ، حدد 
كـ مرة حصؿ ذلؾ خلاؿ 
السنة السابقة 
عدد المرات 
 |_____||_____|  
 |_____|
 
 
 
اذا كانت الاجابة نعم، ما ىي  22HC
 )اسم الطفل(الاسباب وراء فقدان 
 المطعوم؟
 يجب الاجابة عمى جميع الخيارات: 
  لا. 2نعـ             . 1
 76 
 
 
 
 المطعـو غير متوفر .1 
 
 |_____|
خدمة التطعيـ غير  .2 
 متوفرة في المركز
 |_____|
 
عدـ وجود الطاقـ  .3
 المختص
 
 |_____|
عدـ ملائمة جدوؿ  .4 
 المطاعيـ
 
 |_____|
عدـ ملائمة موقع مركز  .5 
 الخدمة
 
 |_____|
عدـ المقدرة عمى  .6 
 الوصوؿ لمكاف الخدمة
 
 |_____|
عدـ المقدرة عمى  .7 
الوصوؿ لمكاف الخدمة 
بسبب عدـ توفر 
 المواصلات العامة
 
 |_____|
 
قمة اىتماـ في أو عدـ  .8
 فيـ لجدوؿ المطاعيـ
 |_____|
 
 مرض الطفؿ .9
 
 |_____|
 
الخوؼ مف الآثار  .01
 الجانبية لممطعـو
 
 |_____|
الخوؼ مف مخاطر  .11 
 السفر
 
 |_____|
 
 التطعيمات غير ميمة .21
 
 |_____|
 
 |_____| حدد ػػػػػػػػػ/أخرى .31
 
ىل سبق وأن عدت الى المنزل بدون 
اسم (الحصول عمى خدمة التطعيم ل 
  ؟)الطفل
 نعـ .1
انتقؿ الى سؤاؿ (لا  .2
 )52HC
 |_____|
اذا كانت الاجابة نعـ، حدد متى 
 حصؿ ذلؾ
  شير|_____||_____| قبؿ 
 شير
 شير
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اذا كانت الاجابة نعم، ما ىي  
الأسباب وراء عودتك الى البيت 
 )اسم الطفل(بدون تمقي المطعوم ل 
 لآخر مرة حصل فييا ذلك؟
 
 يجب الاجابة عمى جميع الخيارات
 
 
  نعم. 1
 لا. 2
 عدـ توفر المطعـو المطموب .1
 .)مثؿ الابرة(عدـ توفر معدات  .2
 غير مؤىؿ لمتطعيـ لأسباب طبية .3
سوء فيـ لجدوؿ المطاعيـ  أو تاريخ  .4
 التطعيـ المطموب
 عدـ وجود الطاقـ المختص .5
 لـ يتـ ابلاغؾ عف السبب .6
عدد كبير مف المراجعيف لكؿ ممرض  .7
 .أو طبيب
 الخدمة متوقفة .8
 عدـ فيـ الموعد .9
 عدـ الحصوؿ عمى موعد مسبؽ .01
 حدد ػػػػػػػ/أخرى .11
  . |_____|1
  . |_____|2
  . |_____|3
  . |_____|4
  . |_____|5
  . |_____|6
  . |_____|7
  . |_____|8
  . |_____|9
  .|_____|01
  .|_____|11
ما ىي الآثار الجانبية التي قد تنتج  52HC
 عن اعطاء المطعوم لمطفل؟
 
 لا تقرأ أي من الآثار المذكورة
 يجب الاجابة عمى جميع الخيارات
  نعم. 1
  لا. 2
 حمى .1
تقرحات  .2
 انتفاخ .3
 احمرار .4
 )الحكة(تييج  .5
 طفح جمدي .6
 لا أعرؼ .7
 حددي ػػػػػػػ/ أخرى  .8
  . |_____|1
  . |_____|2
  . |_____|3
  . |_____|4
  . |_____|5
  . |_____|6
  . |_____|7
  . |_____|8
 
أي من الآثار التالية  )ىل لاحظت 62HC
  اسم الطفل عند تطعيمو؟(عمى 
اقرأ جميع الخيارات الموجودة، 
 ويجب الاجابة عمى جميع الخيارات
 نعم. 1
لا . 2
اذا كانت الاجابة عمى جميع 
 الى سؤال لانتق )لا(الخيارات 
  .82 HC
 
  .1
 حمى .2
تقرحات  .3
 انتفاخ .4
 احمرار .5
 )الحكو(تييج  .6
 طفح جمدي .7
 حددي ػػػػػػػ/أخرى  .8
  . |_____|1
  . |_____|2
  . |_____|3
  . |_____|4
  . |_____|5
  . |_____|6
  . |_____|7
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عندما لا حظت أحد الآثار التي  72HC
ذكرت أعلاه عمى طفمك، ماذا 
 فعمت؟
 
يجب الاجابة عمى 
 جميع الخيارات
 نعم. 1
 لا. 2
 .لا شيء، كانت آثار عادية .1
المستشفى /ذىبت الى الطبيب .2
. لمراجعة المختصيف
 .استخدمت العلاجات البيتية .3
 .لـ أعطو المطعـو التالي .4
 .حولت مساعدتو، لكف لـ أستطع .5
استعنت بأحد مف  .6
 الاصدقاء/الاقارب
 حددي ػػػػػػػػ/أخرى .7
  . |_____|1
  . |_____|2
  . |_____|3
  . |_____|4
  . |_____|5
  . |_____|6
  . |_____|7
 
اسم (خلال الزيارة الأخيرة لتطعيم  82HC
  ، ىل أعطي؟)الطفل
 د/نقط مف  فيتاميف أ .1
 شراب حديد .2
  لا. 2نعـ     . 1
 |_____|
 |_____|
أي من  )اسم الطفل(ىل تمقى  92HC
المطاعيم التالية اضافة الى 
 المطاعيم الأخرى؟
 
 مطعـو التياب السحايا .1
 Aمطعـو التياب الكبد نوع  .2
 الحصبة الألمانية .3
 جدري الماء .4
 حددي ػػػػ/مطاعيـ أخرى .5
 لا    .3لا     . 2نعـ     . 1
 أعرؼ
  . |_____|1
  . |_____|2
  . |_____|3
  . |_____|4
  . |_____|5
كيف تقييمن رضاك عن خدمة  03HC 
التطعيم التي تمقييا عند تطعيمك 
في المركز الذي تم  )اسم الطفل(
  آخر مرة؟ )اسم الطفل(تطعيم 
 مرضي جدا ً .1
. مرضي .2
 .بيف بيف .3
 غير مرضي .4
 غير مرضي بشكؿ كبير .5
 |_____|
 )اسم الطفل(ىل ستقومين بتطعيم  13HC
في نفس المركز الذي طعمت طفمك 
 فيو آخر مرة؟
 .نعـ بالتأكيد .1
غير متأكدة  .2
 )33HCانتقمي الى (لا نيائيًا  .3
 لا ينطبؽ .4
 |_____|
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 23HC
اذا كانت الاجابة نعم، ما ىي 
اسم (الأسباب التي ستجعمك تطعيم 
  في نفس المركز؟ )الطفل
 
 يجب الاجابة عمى جميع الخيارات
  نعم. 1
لا . 2
 
 
المكاف الوحيد الذي يسيؿ  .1
 .الوصوؿ اليو
. مجانية الخدمة .2
 المركز يزودني بحوافز، كالطعاـ .3
 سمعة المركز جيدة .4
 الرضى عف الخدمة المقدمة .5
 حددي ػػػػػػػ/أخرى .6
  . |_____|1
  . |_____|2
  . |_____|3
  . |_____|4
  . |_____|5
  . |_____|6
 
 33HC
ما ىي الأسباب التي دفعتك لمبحث 
اسم (عن مكان آخر لتطعيم 
  ؟)الطفل
 
 يجب الاجابة عمى جميع الخيارات
  نعم. 1
 لا. 2
 .جودة الخدمة غير جيدة .1
عدـ المقدرة عمى دفع تكاليؼ  .2
. المطعـو
 المركز غير ملائـ/برنامج العيادة .3
 صعوبة الوصوؿ لمكاف الخدمة .4
الخدمة متوقفة ولا يتوفرالتطعيـ  .5
 المطموب ػػػػػػػػ
  . |_____|1
  . |_____|2
  . |_____|3
  . |_____|4
  . |_____|5
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Appendix Two  Copy of Child Record 
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Appendix Three    Tables 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2 Birth Order    Frequency, Percent Valid Percent*   
 
 Birth Order 
 Frequency Percent 
1 8 2.3 
  
2 - 3 
32 9.2 
  
4- 5 
147 42.5 
  
6- 7 
68 19.7 
  
8 + 
91 26.3 
  
Total 
346 100.0 
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                            Table 4.3 Number of Siblings, Siblings Frequency, Percent Valid Percent    
  
 Number of Sibling Frequency Percent 
 0 
8 2.3 
  1 
22 6.4 
  2 
25 7.2 
  3 
10 2.9 
  4 
16 4.6 
  5 
27 7.8 
  6 + 
238 68.8 
  Total 
346 100.0 
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                                Table 4.4 Mother Education 
 
 Mother Education Frequency Percent 
No Education 6 1.7 
 Some Primary 20 5.8 
 Complete Primary 66 19.1 
 Preparatory school 124 35.8 
 Secondary school + 130 37.6 
 Total 346 100.0 
 
                             Table 4.5 Number of Adherent refugee and Non-refugee by Vaccine Type (%) 
 
 BCG  HB1  IPV1  HB2  dpt1  ipv2  opv1  dpt2  opv2  dpt3  opv3  HB3  Measles  DPT4  TOPV  MMR  
Vaccine Card 
None 
Refugee 91.2 94.7 93.5 88.8 89.8 87.3 86.1 89.4 85.4 87.1 82.6 80.3 84.5 80.9 75.5 74.3 
Refugee 
Camps 89.8 94.0 92.2 92.2 93.3 89.6 92.0 92.1 92.1 90.6 90.6 84.8 82.2 78.0 73.2 74.2 
P-Value 0.397 0.814 0.201 0.868 0.633 0.884 0.297 0.507 0.156 0.199 0.050 0.178 0.592 0.232 0.321 0.347 
 
Mother Recall 
  
None 
Refugee 98.2 100.0 98.2 97.6 97.0 97.0 95.8 96.7 95.4 97.7 95.5 93.9 97.3 94.7 89.4 91.9 
Refugee 
Camps 97.6 100.0 100.0 100.0 98.8 98.2 97.5 99.3 99.3 99.3 99.3 94.2 93.5 90.2 84.1 93.5 
P-Value 0.202 1.000 0.305 1.000 0.843 1.000 0.852 0.121 0.090 0.464 0.245 0.495 1.000 0.634 0.545 0.386 
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                                  Table 4.6 Number of Adherent refugee and Non-refugee by Vaccine Type (n) 
 
 
 
 
 
 
  
  
  
  
  
 BCG  HB1  IPV1  HB2  dpt1  ipv2  opv1  dpt2  opv2  dpt3  opv3  HB3  Measles  DPT4  TOPV  MMR  
Vaccine Card 
None 
Refugee 155 161 159 151 149 145 143 135 129 115 109 106 93 76 71 55 
Refugee 
Camps 149 156 153 153 152 146 150 139 139 125 125 117 88 64 60 46 
Total 304 317 312 304 301 291 293 274 268 240 234 223 181 140 131 101 
Mother Recall 
None 
Refugee 167 170 167 166 161 161 159 146 144 129 126 124 107 89 84 68 
Refugee 
Camps 162 166 166 166 161 160 159 150 150 137 137 130 100 74 69 58 
Total 329 336 333 332 322 321 318 296 294 266 263 254 207 163 153 126 
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  Table 4.7. Percentage of children up-to-date at age 2 years, by type of vaccination, according to mother recall 
 
Antigens BCG  HB1  IPV1  HB2  dpt1  ipv2  opv1  dpt2  opv2  dpt3  opv3  HB3  Measles  DPT4  TOPV  MMR  
Vaccine 
Card  90.5 94.3 92.9 90.5 91.5 88.4 89.1 90.7 88.7 88.9 86.7 82.6 83.4 79.5 74.4 74.3 
Mother 
Recall 97.9 100.0 99.1 98.8 97.9 97.6 96.7 98.0 97.4 98.5 97.4 94.1 95.4 92.6 86.9 92.6 
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                                              Table 4.8 Vaccination by Background Characteristics (Cards) 
 
 
  
Child Card BCG HB1 IPV1 HB2 dpt1 ipv2 opv1 dpt2 opv2 dpt3 opv3 HB3 Measles DPT4 TOPV  MMR 
Total 
Coverage 
without 
MMR N 
Gender                                     
Male 88.4 93.1 92.5 89 90.5 87.5 88.1 91.1 88 89.2 84.9 84.2 84.3 80.9 73 59.6 64 178 
Female 92.6 95.7 93.3 92 92.5 89.4 90.1 90.3 89.6 88.5 88.5 80.9 82.4 78.2 75.9 56.3 59.8 168 
Total 90.5 94.3 92.9 90.5 91.5 88.4 89.1 90.7 88.7 88.9 86.7 82.6 83.4 79.5 74.4 58 61.9 346 
Locality 
None Refugee 91.2 94.7 93.5 88.8 89.8 87.3 86.1 89.4 85.4 87.1 82.6 80.3 84.5 80.9 75.5 58.5 63.8 173 
Refugee Camps 89.8 94 92.2 92.2 93.3 89.6 92 92.1 92.1 90.6 90.6 84.8 82.2 78 73.2 57.3 59.8 173 
Total 90.5 94.3 92.9 90.5 91.5 88.4 89.1 90.7 88.7 88.9 86.7 82.6 83.4 79.5 74.4 58 61.9 346 
Birth Order 
1 100 100 87.5 100 100 75 100 87.5 87.5 85.7 85.7 71.4 100 100 100 50 50 8 
2-3 90.6 93.8 93.8 93.8 87.5 87.5 84.4 90 90 85.2 85.2 85.2 82.6 90 80 65 70 32 
4-5 91.6 95.1 92.3 90.2 93.5 90.6 89.9 93.8 90.6 92.1 86.8 81.6 85.7 83.3 78.8 65.2 65.2 147 
6-7 90.8 93.8 93.8 92.3 92.3 90.8 90.8 88.5 86.9 90.2 88.2 82.4 84.4 65.8 63.2 52.6 52.6 68 
8+ 87.5 93.2 93.2 87.5 88.2 84.7 87.1 88 86.7 84.5 85.9 84.5 78 79.2 72.9 50 62.5 91 
Total 90.5 94.3 92.9 90.5 91.5 88.4 89.1 90.7 88.7 88.9 86.7 82.6 83.4 79.5 74.4 58 61.9 346 
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Child Card BCG HB1 IPV1 HB2 dpt1 ipv2 opv1 dpt2 opv2 dpt3 opv3 HB3 Measles DPT4 TOPV  MMR 
Total 
Coverage 
without 
MMR N 
Number of Sibling  
0 100 100 87.5 100 100 75 100 87.5 87.5 85.7 85.7 71.4 100 100 100 50 50 8 
1 86.4 95.5 86.4 90.9 90.9 81.8 86.4 89.5 89.5 94.1 94.1 82.4 80 78.6 71.4 71.4 57.1 22 
2 100 95.8 100 87.5 100 100 83.3 100 86.4 95.2 76.2 85.7 93.8 100 91.7 75 66.7 25 
3 100 100 100 90 100 90 90 100 87.5 100 87.5 87.5 87.5 71.4 71.4 57.1 57.1 10 
4 73.3 73.3 73.3 73.3 73.3 73.3 73.3 73.3 73.3 71.4 71.4 64.3 66.7 44.4 44.4 33.3 44.4 16 
5 96 100 100 100 100 100 96 100 96 100 95.5 95.5 100 100 100 58.3 91.7 27 
6 + 89.7 94.4 93.1 90.5 90.2 88 89.8 89.8 89.3 87.3 87.3 82.3 81.4 78 72 56.8 61 238 
Total 90.5 94.3 92.9 90.5 91.5 88.4 89.1 90.7 88.7 88.9 86.7 82.6 83.4 79.5 74.4 58 61.9 346 
Mother Education 
No Education 83.3 100 100 100 100 100 100 100 100 100 100 100 66.7 100 66.7 66.7 66.7 6 
Some Primary 95 100 95 90 88.2 82.4 94.1 100 100 80 80 73.3 84.6 90 90 70 50 20 
Primary 92.4 93.9 93.9 90.9 92.3 87.7 92.3 90.2 90.2 94.4 92.6 87 77.8 69.4 69.4 55.6 55.6 66 
Preparatory school 90 93.3 92.5 89.2 89.1 87.4 84.9 87 84.3 86 83 79 83.5 81 71.4 49.2 60.3 124 
Secondary school + 89.5 94.4 91.9 91.1 93.5 90.2 90.2 92.9 90.2 89.7 87.6 84.5 87 81.3 78.1 65.6 68.8 130 
Total 
90.5 94.3 92.9 90.5 91.5 88.4 89.1 90.7 88.7 88.9 86.7 82.6 83.4 79.5 74.4 58 61.9 346 
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                                              Table 4.9 Vaccination by Background Characteristics (Mother Recall)) 
 
 
 
Mother Recall BCG HB1 IPV1 HB2 dpt1 ipv2 opv1 dpt2 opv2 dpt3 opv3 HB3 Measles DPT4 TOPV 4 MMR 
Total 
Coverage 
without 
MMR N 
Male 98.3 100 99 98 98 97 97 99 98 99 96 95 96.5 96.6 88.8 74.2 85.7 178 
Female 97.5 100 99 99 98 98 96 97 97 99 99 93 94.1 88.5 85.1 71.3 79.3 168 
Total 97.9 100 99 99 98 98 97 98 97 99 97 94 95.4 92.6 86.9 72.7 82.5 346 
  
None Refugee 98.2 100 98 98 97 97 96 97 95 98 96 94 97.3 94.7 89.4 72.3 83.9 173 
Refugee Camps 97.6 100 100 100 99 98 98 99 99 99 99 94 93.5 90.2 84.1 73.2 80.8 173 
Total 97.9 100 99 99 98 98 97 98 97 99 97 94 95.4 92.6 86.9 72.7 82.5 346 
Birth Order 
1 100 100 100 100 100 88 100 100 100 100 100 86 100 100 75 100 50 8 
2-3 96.9 100 100 100 97 97 94 97 97 96 96 96 100 100 90 70 89.5 32 
4-5 97.9 100 99 98 99 98 97 100 99 99 97 93 100 95.5 90.9 80.3 87.5 147 
6-7 100 100 100 100 99 99 99 95 95 100 98 96 95.6 84.2 81.6 65.8 73 68 
8+ 96.6 100 99 99 97 98 95 97 96 97 97 94 86.4 91.7 85.4 66.7 81.8 91 
Total 97.9 100 99 99 98 98 97 98 97 99 97 94 95.4 92.6 86.9 72.7 82.5 346 
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Mother 
Recall BCG HB1 IPV1 HB2 dpt1 ipv2 opv1 dpt2 opv2 dpt3 opv3 HB3 Measles DPT4 
TOPV 
4 MMR 
Total 
Coverage 
without 
MMR N 
Number of Sibling  
0 100 100 100 100 100 88 100 100 100 100 100 86 100 100 75 100 50 8 
1 90.9 100 100 100 96 91 91 100 100 100 100 94 100 92.9 85.7 85.7 78.6 22 
2 100 100 100 96 100 100 96 100 100 95 95 91 100 100 91.7 75 83.3 25 
3 100 100 100 100 100 100 100 100 100 100 100 100 87.5 100 100 57.1 100 10 
4 100 100 100 100 100 100 100 100 100 100 100 93 100 100 100 88.9 88.9 16 
5 100 100 100 100 100 100 96 100 96 100 96 100 100 100 100 75 100 27 
6 + 97.8 100 99 99 97 98 97 97 97 98 97 94 93.8 89.8 83.9 69.5 80.2 238 
 Total 97.9 100 99 99 98 98 97 98 97 99 97 94 95.4 92.6 86.9 72.7 82.5 346 
Mother Education 
No 
Education 100 100 100 100 100 100 100 100 100 100 100 100 66.7 100 66.7 66.7 66.7 6 
Some 
Primary 100 100 100 100 100 100 100 100 100 100 100 93 92.3 90 90 80 75 20 
Primary 100 100 99 100 97 95 97 95 95 100 96 96 88.9 86.1 86.1 69.4 79.4 66 
Preparatory 
school 97.5 100 99 98 98 98 97 99 99 98 98 92 100 98.4 87.3 73 83.3 124 
Secondary 
school + 96.8 100 99 98 98 98 96 98 96 98 97 95 96.1 90.6 87.5 73.4 85.2 130 
Total 
97.9 100 99 99 98 98 97 98 97 99 97 94 95.4 92.6 86.9 72.7 82.5 346 
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Table 4.10 Agreement on individual children's up-to-date vaccination status: parental recall versus medical 
records and vaccination cards versus medical records  
 
 
 n Vaccination card vs. Mother Recall Mother Recall Kappa 
BCG  334 306 28 0.400 
HB1  346 327 19 0 
IPV1  334 311 23 0.415 
HB2  333 305 28 0.450 
dpt1  322 301 21 0.665 
ipv2  321 291 30 0.584 
opv1  318 293 25 0.655 
dpt2  297 275 22 0.780 
opv2  295 269 26 0.753 
dpt3  266 240 26 0.802 
opv3  263 233 30 0.773 
HB3  254 223 31 0.785 
Measles  210 181 29 0.831 
DPT4  171 145 26 0.849 
TOPV  156 132 24 0.852 
MMR  129 102 27 0.826 
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Appendix Four 
 
Biographical Sketch  
  
 C. Carol McCormick was born in New Orleans, April 3, 1950, and was raised in 
Apalachicola, Florida. She graduated from Chapman High School and received her 
Bachelors of Science Degree in Nursing from Florida State University in 1972. Her 
career has been devoted to Pediatric Nursing primarily in community health settings. In 
1984, she developed the Tallahassee Pediatric Foundation (TPF) Primary Care Program 
as a pilot, nurse case-managed, private sector based, medical home model for indigent 
children. The Program, which is contracted through the Department of Health, Children’s 
Medical Services, now serves over 8200 children, and has been replicated in many other 
areas of the state.  
 She looks forward to finishing her career at TPF, resuming hobbies like fishing and fly 
tying and spending more time at the beach with her family and new grand-niece, the most 
beautiful baby in the world, Emily.  
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Appendix Five Request for UNRWA Approval 
 
To: UNRWA director of operation –West Bank 
 
From: Dr. Suleiman Ghosheh  
 Obstetrician Jerusalem Area \ Field office  
 
Subject: Request for Thesis Approval  
 
Dear Sir, 
 
As you know, I was sent by the health department for a master degree in public health, 
reports about my performance were submitted regularly to the training committee. 
 
Now I am in the thesis phase, the previous topic chosen by me about the periodic report 
appraisal did no get a positive answer. Now and after consultation with the health 
department my thesis is going to be about adherence rate for Palestinian children at 2 
years of age, comparison between refugee and non-refugee. 
This is going to be a post facto survey with comparison between the mother recall, child 
record and UNRWA clinical records, with additional data collection. 
 
I need your approval to use the UNRWA facilities in the three areas of operation and to 
be allowed to use the clinical records available in the clinics. 
 
Wish to have your approval,  
          
With respect…. 
          
 
         Dr. S. Ghosheh 
 
 
10.05.2005 
C.C: Training Committee   
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  :الممخص التنفيذي 
  تمقارنة مدى التزام الاطفال الفمسطينيين اللاجئين  وغير اللاجئين حتى عمر السنتين بالثطعيما
 طفؿ لاجىء 643وتبيف الخصائص الاجتماعيو ؿ، ىذة الدراسة تقارف في نسبة الالتزاـ بالتطاعيـ
       .وغير لاجىء في الضفة الغربية وقطاع غزة
فرضية ىذة الدراسة كانت باف صفة اللاجىء ليست السبب الاولي قي عدـ الالتزاـ بالتطعيـ لدى 
  .ىذة الفئو
اف عممية التزود بالمعمومات لاثبات ىذة الفرضية ضروري جدا مف اجؿ تحسيف نسبة الالتزاـ 
  .الفئو بالمطاعيـ لدى ىذة
تثبت ىذة الدراسة الفرضية المذكورة وذلؾ باظيار اف الاطفاؿ غير اللاجئيف ليسوا اقؿ بكثير التزاما 
كما وتظير مدى اىمية التركيز عمى المشورة مف اجؿ جمب العدد الاكبر مف ، مف الاطفاؿ اللاجئيف
 غير الممتزميف
كاطار ليذة  )7991بندؿ  ( تـ في ىذة الدراسة استخداـ نموذج بندؿ لمتعزيز والتثقيؼ الصحي
، وىذا يؤدي بالضرورة لفيـ سموكيات التوعية الصحية والوقاية لدى الافراد في ىذة الدراسة، الدراسة
وكما اثبتت ىذة .اف التركيز في ىذة الدراسة كاف عمى سموكيات الاىؿ في طمب التطاعيـ للاطفاليـ
الدراسة فاف اىؿ الاطفاؿ غير اللاجئيف ىـ الذيف ينجحوف اكثر قي التغمب عمي المعيقات اماـ 
  .  حصوؿ اطفاليـ عمي التطعيمات
 
 
